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1.1 General features of zygomycetes 
The zygomycetes represent approximately 1% of the species of fungi described 
so far (Kirk et al., 2001). The number of fungal species that exist is estimated to be 
around 1.5 million (Hawksworth, 1991, 2001; Kirk et al., 2001), so the number of 
zygomycetes not yet found could be around 10.000 (Hawksworth, 1991, 2001; 
Hawksworth and Rossman, 1997; Kirk et al., 2001). It has been postulated that the 
zygomycetes were the first species of fungi to colonize the land, even before the plants 
(about 600 million years ago) (Berbee and Taylor, 2001; Heckman et al., 2001). Their 
ancestors developed several strategies for interacting with plants, animals and other 
organisms, ranging from parasitic to mutualistic symbiotic associations. Like other 
fungi, zygomycetes are heterotrophic and grow inside the substrate, dissolving it with 
extracellular enzymes and taking up nutrients by absorption. They act as decomposers 
in soil and dung, thereby playing a significant role in the carbon cycle. Some 
zygomycetes are important in industry as biocatalysts in the production of steroids, due 
to the production of organic acids (citric and gluconic) and carotenoid compounds, and 
because they are involved in various fermented food processes (Certik and Shimizu, 
1999; Hesseltine and Ellis, 1973). Some species are used in several Asian foods, for 
example Rhizopus oligosporus in tempeh, and Actinomucor elegans in the fermentation 
of sufu (Hesseltine, 1991). By contrast, several species, for example Rhizopus stolonifer 
and Choanephora cucurbitarum have a negative impact on the economy, causing rot 
during the storage of plants and meat. Other species like Apophysomyces elegans, 
Mucor circinelloides, Rhizopus oryzae, and Saksenaea vasiformis, are able to infect 
both immunocompromised and immunocompetent people (de Hoog et al., 2000; Ribes 
et al., 2000; Roden et al., 2005). Some of these species are commonly isolated from 
animals and soil in tropical and subtropical areas. 
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The zygomycetes are characterized by a fast growth on high sugar content 
substrates, such as berries and grapes. These fungi are common in both terrestrial and 
aquatic environments, having a worldwide distribution. Macroscopically, they show an 
expanding mycelium with a woolly appearance (Fig. 1a), mainly white-gray (rarely 
orange or brown), which can reach several centimeters in height, as in the Blakeslea and 
Phycomyces species. Microscopically, they are characterized by thin-walled hyphae 
(Fig 1b, c), composed mainly of the polysaccharides chitin and glucans, and branched in 
right angles. Unlike the ascomycetes and the basidiomycetes, whose hyphae are 
regularly septate, most of the zygomycetes usually (with the exception of the members 
of the classes Kickxellales and Harpellales) present coenocytic (not divided by septa) 
hyphae (Fig 1b, c). A unique character that defines the zygomycetes is the production of 
sexual spores called zygospores (Fig. 1d), which are usually pigmented structures with a 
smooth or rough-walled surface, formed by the fusion of specialized hyphae 
(gametangia; Fig. 1e) during the sexual phase (Benjamin, 1979; Benny et al., 2001). 
They have the ability to remain dormant for a long period of time, and in favorable 
environmental conditions they can germinate, producing a new cycle of life. 
Asexual reproduction in zygomycetes is based on the production of numerous 
propagules called sporangiospores (Fig. 1f, g), which are distinguished from other types 
of asexual spores, such as the conidia in Ascomycota and Basidiomycota, by its internal 
production through a split in the cytoplasm of the sporangium (Fig. 1h), a vesicle 
located in the extremity of the fertile hyphae (= sporangiophore; Fig. 1i). The hyphae 
walls then dissolve and the spores are released, being spread by wind, water or animals 
(e.g. arthropods) (Richardson, 2009). The zygomycetes can also produce globose and 
uni- to few-spored sporangia (= sporangiola; Fig. 1j), and cylindrical sporangia (= 
merosporangia; Fig. 1k), in which the sporangiospores are disposed in a chain-like 
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series. A sterile central axis within the mature sporangia (= columella; Fig. 1l) is usually 
present in many individuals. 
Under adverse environmental conditions, the zygomycetes can form arthrospores 
and chlamydospores (both, a sort of thallic propagule developed from remodeling of the 
cell wall of a pre-existent hyphae), or blastospores (propagules of neo-formation) 
(Benny, 1995). Certain vegetative structures, such as rhizoids (root-like structures 
acting as resting and feeding organs; Fig. 1m) and stolons (“running” hyphae; Fig. 1n), 
















Figure 1. Typical features of the zygomycetes. a, colony; b, coenocytic hypha; c, section 
of a hypha; d, zygospore; e, gametangium; f, sporangiospores; g, merospores; h, 
sporangium; i, sporangiophore; j, sporangiole; k, merosporangia; l, columella; m, 
rhizoids; n,  stolon (taken from Guarro et al., 1999).  
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1.2 Taxonomy and phylogeny 
 
Traditionally, the classification of the zygomycetes has been based on 
phenotypic characters, mainly from the morphological features of the sexual and 
asexual reproductive structures, but also in the presence and features of certain 
differentiated vegetative structures, such as stolons and rhizoids (Benny, 1995; 
Hoffmann et al., 2009). Several authors have reported the taxonomic importance of the 
zygospore in the identification/classification of this group of fungi (Benjamin, 1979; 
Weitzman et al., 1995). Sexual mating (heterothallic or homothallic nature of the taxa), 
the ornamentation of the zypospores and the suspensors (hyphae that support the 
gametangia) (Fig. 2) have been used to solve some taxonomical controversies 
(Hoffmann et al., 2007), such as in Absidia / Mycocladus / Lichtheimia (Hoffmann et 
al., 2007, 2009). Nevertheless, some studies have demonstrated the usefulness of the 
size and shape of sporangiospores in their taxonomical classification (Garcia-Hermoso 
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Figure 2: Some types of zygospores, zygospore appendages, and suspensors (from 
Webster and Weber, 2007). 
 
On the other hand, the use of physiological tests as a taxonomical tool, such as 
the assimilation of different carbon and nitrogen sources, are less frequently employed, 
but they are useful for discriminating between some species of clinical importance 
(Schwarz et al., 2007; Vastag et al., 1998). 
The zygomycetes have suffered a series of changes to their nomenclature. A 
summary of their successive taxonomic placements is summarized in Table 1. These 
changes in their taxonomic denomination could explain why the zygomycetes have been 
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Benny (1995) pointed out the limitations of the morphological features in the 
species delimitation within certain zygomycetes, suggesting the use of molecular tools
for solving existing taxonomic controversies. O´Donnell et al. (1994) also suggested 
that the traditional classification scheme for the zygomycetes does not reflect the
phylogenetic relationships between their taxa. A later molecular study, which included a 
large set of species belonging to the zygomycetes and based on the analysis of the 
sequences of three different genes (18S rDNA, 28S rDNA and elongation factor 1-α 
[EF1-α]) concluded that several of the recognized families, including the Mucoraceae, 
were polyphyletic (O'Donnell et al. 2001). In recent years, several studies based on 
multilocus analysis (18S, 28S, EF1-α, RNA polymerase II subunits 1 and 2 and the 
mitochondrial complete genome) have confirmed the polyphyletic nature of the 
zygomycetes (Hibbet et al., 2007; James et al., 2006; Tanabe et al., 2004, 2005; Voigt
et al., 1999; White et al., 2006). Based on these reports, a new scheme was proposed, 
based on the monophyletic relationships comprising the subphyla (= subdivisions) 
Entomophthoromycotina, Kickxellomycotina, Mucoromycotina and Zoopagomycotina; 
the orders Zoopagales and Entomophthorales were assigned to the subphylum 
Zoopagomycotina and Entomophthoromycotina, respectively; the Kickxellales, 
Dimargaritales, Harpellales and Asellariales, to the Kickxellomycotina; and the
Mucorales, Endogonales and Mortierellales to the subphylum Mucoromycotina, which 
includes 61 genera and around 325 species (Hibbet et al., 2007; Kirk et al., 2008) (Figs. 
3 and 4). Currently, therefore, none of the terms Zygomycetes, Zygomycotina or 
Zygomycota are valid for taxonomic denomination of the zygomycetes, because they do 
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Figure 3. Phylogeny and classification of the Fungi. Highlighted in green: the taxa 
pertaining to the obsolete phylum Zygomycota. Dashed lines: taxa with uncertain 
placement (incertae sedis). Adapted from Hibbet et al. (2007). 
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 Figure 4. Genera belonging to the order Mucorales. 
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Four orders of zygomycetes, Basidiobolales, Mortierellales, Mucorales and 
Entomophtorales, include the most important taxa implicated in animal infections. 
However, most of the animal (and human) pathogenic species are within the Mucorales, 
such as species of the genera Mucor, Rhizomucor and Rhizopus (family Mucoraceae), 
and of Absidia (formally Lichtheimia) (family Absidiaceae). A fungal infection due to 
members of the Mucorales is commonly named mucormycosis, but also as 
zygomycosis, an alternative term which has become less accurate based on the recent 
taxonomic reclassification of the zygomycetes (Spellberg et al., 2009b; Kontoyiannis et 
al., 2011). 
 
1.3 Epidemiology of the mucormycosis 
In recent years the clinical range of the infections caused by zygomycetes has 
changed dramatically, because of the increase in the number of the 
immunocompromised patients (Meis and Chakrabarti, 2009). Roden et al. (2005), in the 
broadest retrospective study on human mucormycosis carried out in the USA (929 
cases), found that there was a 70% increase in the number of cases reported between 
1940 and 2000. A comparable result (a 40% increase) was found in another 
retrospective study carried out in France (531 cases) between 1997 and 2006 (Bitar et 
al., 2009). Saegeman et al. (2010), in a recent study at a university hospital in Leuven, 
Belgium, also reported a significant increase in the annual incidence of mucormycosis, 
from 0.019 to 0.148 cases/10.000 patients/day between 2000 and 2009. 
All of those authors remarked that the infections caused by zygomycetes were 
frequently associated to neutropenic patients, transplant recipients, patients with 
hematological disorders or diabetes mellitus, patients receiving deferoxamine therapy, 
and intravenous drug users. 
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Roden et al. (2005) reported that the frequency of infections by organ type 
involved was: rhino-orbito-cerebral (66% of diabetic patients), pulmonary (around 25% 
of all cases), followed by cutaneous, disseminated, and gastrointestinal. Despite no 
information about locations being available for 30.3% of patients, in a study developed 
in France (Bitar et al., 2009) the presentations included digestive tract (23.2%), 
pulmonary (18.5%), rhino-cerebral (11.8%), and cutaneous localizations (9.4%), and 
disseminated in 6.8% of the cases. However, the locations found by Saegeman et al. 
(2010) differed from the other authors: 51.5% of infections were pulmonary, 23% 
disseminated, 13% cutaneous, 6.5% sinus, 3% cerebral, and 3% mycetoma. Moreover, 
these authors mentioned a high percentage (45%) of co-infections with Aspergillus spp. 
Most of the clinically important zygomycetes are in the order Mucorales, and 
comprise approximately 60 genera. Roden et al. (2005) established that the most 
prevalent species were Rhizopus oryzae (nearly half of all isolates), followed by R. 
microsporus, Mucor circinelloides, Absidia (= Lichtheimia) corymbifera, Rhizomucor 
pusillus, Cunninghamella bertholletiae, Mucor indicus, Cunninghamella echinulata, 
and Apophysomyces elegans. Three recent retrospective studies carried out in the USA 
(Kontoyiannis et al., 2000, 2005; Sims et al., 2007) included a significant number of 
cases (24, 27 and 26, respectively). However, one of these (Sims et al., 2007) 
distinguished only between Mucor spp. and Rhizopus spp., and in the others two 
(Kontoyiannis et al., 2000, 2005), only the genera were mentioned (Cunninghamella, 
Mucor, Rhizopus, and Syncephalastrum). Despite the authors mentioning the 
mycological methods used to identify those fungi (culture-based [Kontoyiannis et al., 
2000, Roden et al., 2005; Sims et al., 2007] and culture- and sequencing-based 
[Kontoyiannis et al., 2005]) in a high number of the cases the identification methods 
were not described, and most of the diagnoses should be considered doubtful or of 
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insufficient accuracy. Unfortunately, there have been no similar studies in other 
countries for comparison purposes. 
The main route of transmission for mucormycosis is by the inhalation of spores 
from environmental sources. It has been demonstrated experimentally that after nasal 
instillation of sporangiospores of Absidia (=Lichtheimia) corymbifera, Cunninghamella 
bertholletiae, Rhizopus oryzae, R. microsporus var. rhizopodiformis, or Rhizomucor 
pusillus an upper and/or lower respiratory infection develops which can disseminate to 
the central nervous system (Kamei, 2001; Reinhardt et al., 1981; Waldorf and Diamond, 
1984). Outbreaks of rhino-cerebral and pulmonary mucormycosis have been described 
in workers by exposure to aerosols generated in excavation sites, during building 
construction or renovation, and by inadequate manipulation of contaminated air-
conditioner filters (England et al., 1981; Krasinski et al., 1985; Richardson, 2009). 
The agents of mucormycosis are unable to penetrate through unbroken skin to 
produce cutaneous infection; however, burns, traumatic disruptions or macerations of 
the skin (Ledgard et al., 2008; Stewardson et al., 2009; Vega et al., 2006), insect bites 
or stings, (Lechevalier et al., 2008; Saravia-Flores et al., 2010), birds pecks (Wilson, 
2008), traumatic inoculations (Andresen et al., 2005; Richardson, 2009; Ribes et al., 
2000; Snell and Tavakoli, 2007), and any process of skin disruption can facilitate the 
implantation and colonization of tissues by the spores. Cutaneous infections can be very 
invasive, also affecting subcutaneous tissues and the adjacent fat, fascia, muscle, and 
finally bone. In addition, the fungus can affect deep solid organs by hematogenous 
dissemination. 
Gastrointestinal mucormycosis is very uncommon. The ingestion of food or 
fermented drinks contaminated with spores may play a role in promoting gastric 
infections and, although it is rare in humans, it can significantly affect animals, i.e. 
UNIVERSITAT ROVIRA I VIRGILI 
TAXONOMY AND PHYLOGENY OF CLINICALLY IMPORTANT MUCORALEAN FUNGI 
Eduardo Álvarez Duarte 
DL: T-1721-2011 
amphibians, bovines and rodents (Creeper et al., 1998; Jensen et al., 1994; Ohbayashi, 
1971; Oliver et al., 1996; Richardson, 2009; Sandford et al., 1985; Speare et al., 1997). 
In the past decade, there has been a reported increase in the incidence of several 
types of mucormycosis in immunocompetent people, principally due to the species 
Apophysomyces elegans and Saksenaea vasiformis (Baradkar and Kumar, 2009; Meis 
and Chakrabarti, 2009; Stewardson et al., 2009). Infections by A. elegans have been 
reported commonly from tropical and subtropical countries, especially India, where 
around of the 50% of the total number of cases in the world annually occur (Chakrabarti 
et al., 2003, 2006, 2009; Devi et al., 2008; Jain et al., 2006; Meis and Chakrabarti, 
2009; Ribes et al., 2000). 
An additional factor in the increasing of the mucormycosis has been the use of 
voriconazole for prophylaxis or empirical therapy. Several studies have reported cases 
of breakthrough mucormycosis in patients receiving that antifungal drug (Lionakis and 
Kontoyiannis, 2005; Marty et al., 2004; Pongas et al., 2009; Singh et al., 2009; Trifilio 
et al., 2007). In this way, voriconazole treatment might be associated with the 
expression of virulence factors such as proteases or siderophores by the fungus. 
Nevertheless, until now the role of voriconazole in the development of mucormycosis 
has remained unclear (Kontoyiannis et al., 2011; Lamaris et al., 2009). 
 
1.4 Clinical presentations of mucormycosis 
Based on the clinical presentation and the part of the body affected, 
mucormycosis are divided in five clinical categories: rhino-cerebral, pulmonary, 
cutaneous, gastrointestinal, and disseminated. In the largest study ever carried out on 
mucormycosis, Roden et al. (2005) observed that sinus infections were the most 
common (39%), followed by pulmonary (25%), cutaneous (19%), and gastrointestinal 
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(7%) infections. Dissemination of the infection was observed in approximately 23% of 
cases. 
 1.4.1 Rhino-cerebral mucormycosis 
The clinical manifestation of this infection is characterized by the involvement 
of the paranasal sinuses, although the maxillary sinus, the orbit, cavernous sinuses, and 
the brain can also be affected (Schutz et al., 2006; Sörensen et al., 2006; Sundaram et 
al., 2005). Rhino-cerebral mucormycosis is commonly observed in patients with 
uncontrolled diabetes mellitus, usually with a remarkable keto-acidosis. In these 
patients, the immune system failed to suppress the germination of spores and to kill the 
proliferating hyphal elements (Ribes et al., 2000) increasing the risk of developing 
mucormycosis. Symptoms can be nasal obstruction, sinus pain, drainage, headache, 
odontalgia, maxillary pain, hyposmia or anosmia. The disease may become rapidly 
progressive, involving the neighbouring tissues. If it extends to the orbital region, 
edema or proptosis can develop and there can be a blurring or loss of vision when the 
optic nerve is reached. The infection can readily progress to the brain, causing an altered 
state of consciousness. The majority of patients with cerebral infections die, though 
mainly due to a delay in diagnosis and treatment (Mantadakis and Samonis, 2009; Ribes 
et al., 2000; Spellberg et al., 2005a). 
 
1.4.2 Pulmonary infection 
Pulmonary mucormycosis is more common in neutropenic patients, and in those 
who undergo haematopoietic stem cell transplantation. Some cases have also been 
described in patients with diabetic keto-acidosis; although the infections in these 
patients are less common and do not cause sudden death; these can follow a sub-acute 
course (Rothstein and Simon, 1986). One of the problems associated to this clinical 
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presentation is the fact that clinical and radiological features are indistinguishable from 
those of other pulmonary mycoses, such as aspergillosis. Symptoms of pulmonary 
mucormycosis include fever, non-productive cough, chest pain, dyspnoea and 
haemoptysis. Unfortunately, the sputum culture for diagnosis is highly unreliable. 
Several reports have shown more than 50% negative cultures in real infections (Lee et 
al., 1999; Reid et al., 2004; Tedder et al., 1994). Without treatment, hematogenous 
dissemination from lungs to other organs frequently occurs, increasing mortality rates 
considerably (Mantadakis and Samonis, 2009; Ribes et al., 2000; Spellberg et al., 
2005a). 
 
1.4.3 Cutaneous infection 
Cutaneous mucormycosis is usually associated to traumatic inoculation, and less 
frequently to disseminated mucormycosis (Roden et al., 2005). The patients are mainly 
immunocompromised, following extensive burn injury or with severe soft tissue trauma 
(Cantatore-Francis et al., 2007; Kobayashi et al., 2001; Mueller and Pabst, 2006; Page 
et al., 2008). In other cases, the infection has followed car accidents, insect bites, and 
traumatic inoculation after natural disasters, like tsunamis and earthquakes (Andresen et 
al., 2005; Devi et al., 2008; Ruiz et al., 2004; Saravia-Flores et al., 2010; Snell and 
Tavakoli, 2007). Symptoms such as erythema and induration are non-specific; necrotic 
scars being the diagnostic hallmark. A prompt biopsy of the involved skin is mandatory, 
due the fast spread to adjacent tissues, especially in neutropenic patients. An often-fatal 
secondary necrotizing fasciitis may occur in these type of infections. Approximately 
44% of cutaneous infections are complicated by extending deeply or by dissemination 
(Roden et al., 2005). Generally, the cutaneous infections have a favourable prognosis 
and a low mortality if aggressive surgical debridement is carried out promptly. 
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1.4.4 Gastrointestinal infection 
Gastrointestinal mucormycosis is uncommon, and has been described mainly in 
infants or in extremely malnourished people (Amin et al., 1998; Sarin, 2010). Apart 
from malnutrition, immunosuppression and ingestion of contaminated food are the most 
common predisposing factors. The infection is characterized by fungal invasion into the 
gut mucosa, submucosa and blood vessels, developing necrotic gastric or intestinal 
ulcers, which may rupture, causing peritonitis (Shiva Prasad et al., 2008).  
 
1.4.5 Disseminated infection 
Disseminated mucormycosis is commonly the result of the spread of a 
pulmonary form, although it may originate from any other primary site of infection 
(Rüping et al., 2010; Tomita et al., 2005). In general, pathogenic Mucorales are 
angioinvasive, able to infect many organs by the hematogenous route (Ribes et al., 
2000). The most common sites of dissemination are the brain, spleen, heart, and skin. 
Cerebral infection following dissemination is distinct from the rhinocerebral 
mucormycosis and results in abscess formation and brain infarction (Spellberg et al., 
2005a). Recently, several cases of mucormycosis have been reported in transplant 
patients under voriconazole prophylaxis (Imhof et al., 2004; Marty et al., 2004; Pongas 
et al., 2009). The diagnosis of disseminated infection is difficult, because patients are 
often severely ill due to other underlying diseases so blood cultures generally remain 
negative. Misidentifications with aspergillosis are common (Spellberg et al., 2005a). 
Disseminated mucormycosis have, in general, a bad prognosis, showing a 
mortality rate near to 90% (Mantadakis and Samonis, 2009; Roden et al., 2005). 
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1.4.6 Atypical presentations 
The Mucorales may cause infection in virtually any anatomical site, although 
some of them are atypical. There have been occasional reports of rare manifestations 
involving the kidneys, usually confirmed at autopsy (Yu and Yu Li, 2006; Singh et al., 
2004; Welk et al., 2004), the trachea (Wolf et al., 2004) and heart and cardiac valves 
(Gubarev et al., 2007; Mehta et al., 2004; Van de Glind et al., 2010). 
 
1.5 Treatment 
Without proper treatment, the mucormycoses are rapidly progressive and lethal. 
In general, the response of the different species of Mucorales to antifungals is quite 
similar, being susceptible to amphotericin B, itraconazole and posaconazole, and more 
or less resistant to the rest of the drugs (Alastruey-Izquierdo et al., 2009; Almyroudis et 
al., 2007; Dannaoui et al., 2002c, 2003c; Dannaoui and Garcia-Hermoso, 2007; Ibrahim 
et al., 2009; Pagano et al., 2009; Rodriguez et al., 2008; Saoulidis et al., 2010; Sun et 
al., 2002a; Spellberg et al., 2009b; Spellberg and Ibrahim, 2010; Takemoto et al., 2010; 
Zhao et al., 2009). 
Lipid preparations of amphotericin B are the only ones active both in vitro 
(Dannaoui et al., 2002b, 2003b; Sun et al., 2002a, Takemoto et al., 2010) and in vivo 
(Dannaoui et al., 2002c; Odds et al., 1998; Sun et al., 2002b, Takemoto et al., 2010) 
against the Mucorales, still today being the treatment of choice against these infections 
(Rüping et al., 2010; Spellberg and Ibrahim, 2010; Takemoto et al., 2010). Lipid 
formulations of amphotericin B, which cause less nephrotoxicity, allows high dosages 
to be administered (Pearson, 2003; Spellberg et al., 2005a; Sun and Singh, 2011). Based 
on experimental models, liposomal amphotericin B at 10 mg/kg/day, in combination 
with surgery, has been proposed as the first line therapy against mucormycosis 
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(Spellberg et al., 2005a, 2009b). In the treatment of cutaneous infections, the use of 
amphotericin B and surgical debridement have also had successful results (Dromer and 
McGinnis, 2002; Ibrahim et al., 2005; Singh et al., 2009). 
Azoles (triazoles) are widely used to treat mycoses other than mucormycosis. 
Posaconazole, a broad-spectrum antifungal drug, showed a good in vitro activity against 
a range of species of Mucorales, especially for Absidia spp., Lichtheimia corymbifera 
and Rhizomucor spp. (Alastruey-Izquierdo et al., 2009; Almyroudis et al., 2007;  
Dannaoui et al., 2003c; Sabatelli et al., 2006; Spreghini et al., 2010; Sun et al., 2002a). 
In vivo, posaconazole significantly prolonged survival in neutropenic mice infected with 
Mucor spp., and reduced fungal burden in kidneys compared to untreated control (Sun 
et al., 2002b). However, in another study on immunocompetent mice with disseminated 
infection, posaconazole was not effective against a Rhizopus oryzae infection (Ibrahim 
et al., 2009), but showed a clear dose-response effect for Rhizopus microsporus 
(Rodriguez et al., 2009) and was partially active against Lichtheimia corymbifera 
(Dannaoui et al., 2003a). Despite the latest in vivo results, and some less frequent 
resistant clinical isolates (Khan et al., 2009), posaconazole has shown good therapeutic 
results, and could be an alternative in the treatment of mucormycosis (Greenberg et al., 
2006; Peel et al., 2008; Spellberg et al., 2009b; Tobon et al., 2003; van Burik et al., 
2006). Recent studies have shown that voriconazole had limited activity against the 
Mucorales (Cornely et al., 2007; Dannaoui et al., 2003b; Espinel-Ingroff, 1998, Sun et 
al., 2002a), and their use in fungal infection prophylaxis was identified as one of the 
factors that favoured the development of mucormycosis (Cornely et al., 2008; Imhof et 
al., 2004; Kontoyiannis et al., 2005; Marty et al., 2004; Singh et al., 2009; Siwek et al., 
2004; Trifilio et al., 2007; Ullmann et al., 2007). In contrast, itraconazole showed in 
vitro species-dependant activity, showing a low MIC (minimal inhibitory concentration) 
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for Lichtheimia and Rhizomucor spp., and a higher MIC, with some intraspecific 
variability, against Rhizopus spp. and Mucor spp. (Almyroudis et al., 2007; Dannaoui et 
al., 2003c; Sabatelli et al., 2006; Sun et al., 2002a). In vivo studies have shown activity 
of itraconazole against Lichtheimia spp. (Dannaoui et al., 2002c, 2003a; Mosquera et 
al., 2001), although being ineffective for Mucor spp. (Sun et al., 2002b), Rhizopus 
microsporus (Dannaoui et al., 2002c, 2003a), and Rhizopus oryzae (Dannaoui et al., 
2002c, 2003a; Odds et al., 1998). 
Due to the limited activity of the majority of the azoles against the 
mucormycosis, a combination of two or more drugs could be of interest (Dannaoui et 
al., 2002a; Dannaoui et al., 2009; Ibrahim et al., 2008; Ogawa et al., 2011; Reed et al., 
2008; Spellberg et al., 2005b). An evaluation of several combinations against 35 
isolates of different species of Mucorales showed that amphotericin B interacted 
synergistically with rifampicin, terbinafine, and voriconazole. Antagonism was not 
observed (Dannaoui et al., 2002a). In another study, the combination of amphotericin B 
with cyclosporine, rapamycin, and tacrolimus were synergic (Dannaoui et al., 2009). 
Chamilos et al. (2006) evaluated the in vitro activity of lovastatin, a 3-hydroxy-3-
methylglutaryl-coenzyme A reductase inhibitor against seven clinical isolates of 
different species of Mucorales: Cunninghamella bertholletiae, Mucor circinelloides, 
Rhizopus homothallicus and R. oryzae, alone and in association with voriconazole, and 
also carried out an in vivo study using a Drosophila melanogaster model of 
mucormycosis. In this study, lovastatin showed significant strain-independent 
fungicidal in vitro activity, showing synergy with voriconazole in all cases. Lovastatin 
was also synergic with voriconazole in the Drosophila model of mucormycosis, itself 
being active in the infection by Mucor circinelloides. More recently, Reed et al. (2008) 
reported that, in patients with cerebral mucormycosis, the response to treatment with 
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lipid complex amphothericin B (ABLC) plus caspofungin was better than with those 
treated only with ABLC therapy. 
Iron is essential for the growth and virulence of Mucorales. A high plasma level 
of free iron produces an increase in susceptibility to mucormycosis (Pagano et al., 
2009). In this context, the use of an iron chelator like deferasirox, alone or in 
combination with other antifungal agents, appears a rational option in the therapy of the 
mucormycosis and is under active investigation (Ibrahim et al., 2006, 2007, 2008; Reed 
et al., 2006; Spellberg, 2005a; 2009a, 2009b; Lewis et al., 2011).  
Nevertheless, due to the lack of a significant number of studies, both in vitro and 
in vivo, as well as a reliable identification at species level of many strains isolated from 
clinical cases, the best antifungal treatment, especially against to uncommon species, 
remains unclear. In fact, despite efforts in the development of new therapeutic 
approaches, mortality rate in mucormycosis patients remains high. 
 
1.6 Molecular phylogeny of the Mucorales 
As was discussed in section 1.2, molecular techniques have proven to be useful 
for solving taxonomical problems of the mucoralean fungi, a group traditionally 
considered homogeneous. In the first comprehensive phylogenetic study carried out by 
O´Donnell et al. (2001), a large panel of genera of Mucorales (63 species belonging to 
54 genera, and 13 families) was analysed, based on the partial nucleotide sequences of 
two nuclear ribosomal genes (18S and 28S) and the translation elongation factor-l-α 
gene (EF 1-) exons. The analysis showed that traditional family-level classification 
schemes for the Mucorales appear to be highly artificial, due to the polyphyletic origin 
of four families within them (Thamnidiaceae, Mucoraceae, Chaetocladiaceae, and 
Radiomycetaceae). Moreover, the resultant phylogram suggested the absence of a 
common ancestor in the evolution of the mucoralean fungi. Recent molecular studies, 
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based on the nucleotide sequence analysis of several loci, including ribosomal DNA 
(Abe et al., 2006, 2007, 2010; Alastruey-Izquierdo et al., 2010; Dannaoui et al., 2010; 
Hoffmann et al., 2007; Garcia-Hermoso et al., 2009; O´Donnell et al., 2001), actin (Abe 
et al., 2007; Hoffmann et al., 2007), EF 1-α (Alastruey-Izquierdo et al., 2010; Abe et 
al., 2007, 2010; Garcia-Hermoso et al., 2009; O´Donnell et al., 2001), and lactate 
dehydrogenase (Saito et al., 2004) genes, have been carried out for phylogenetic species 
recognition and for taxonomical reorganization, all of them confirming the conclusions 
suggested by O´Donnell et al (2001). In this way, the results of polyphasic studies 
strongly support the existence of several monophyletic clades among the Mucorales. 
Thus, Lichtheimia was proposed as a new genus; and their species L. corymbifera, L. 
ramosa, L. sphaerocystis, and L. hongkongensis were considered different species from 
Absidia, as well as the etiological agents of mucormycosis, because of their ability to 
grow at 37ºC (Alastruey-Izquierdo et al., 2010; Hoffmann et al., 2007, 2009; Garcia-
Hermoso et al., 2009; Woo et al., 2010). The new genus Lentamyces (Hoffmann and 
Voigt, 2009) was described to relocate the micoparasitic species L. parricida and L. 
zychae. Finally consider three different genera within the genus Absidia: Absidia, 
Lentamyces and Lichtheimia.  
Other molecular techniques, such restriction fragment length polymorphism 
(RFLP) (Chakrabarti et al., 2003; Larche et al., 2005; Lemmer et al., 2002; Machouart 
et al., 2006; Seif et al., 2005), amplified fragment length polymorphism (AFLP) 
(Chakrabarti et al., 2010; Kito et al., 2009); random amplified polymorphic DNA 
(RAPD) (Papp et al., 2001; Vágvölgyi et al., 2001), and pulsed field gel electrophoresis 
(PFGE) (Diaz-Minguez et al., 1999; Nagy et al., 2000, 2004) have been used relatively 
rarely in the identification/taxonomy of the mucoralean fungi. The banding patterns 
obtained have proven to be useful for the identification of clinical agents of 
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mucormycosis, but have shown a limited species-level discrimination when they are 
compared with the sequencing-based techniques (Chakrabarti et al., 2003, 2010). 
Based on the results of the molecular-based studies, the guidelines for the fungal 
identification by DNA sequencing were published by the CLSI (CLSI, 2007). For the 
Mucorales, the ITS region was proposed as the gold standard for generic and species 
identification. The Working Group on Fungal Molecular Identification of the 
International Society of Human and Animal Mycology (ISHAM) supported this 
proposal (Balajee et al., 2009).  
DNA barcoding, a technique for identifying organisms based on a short and 
standardized fragment of genomic DNA (because it is like a barcode tag for each 
taxon), has a promising future. Applying the barcoding makes it possible to achieve a 
more precise delimitation of species and subspecies and to discriminate between 
morphologically similar species. DNA barcoding can be a powerful tool when used in 
conjunction with the traditional methods for identifying specimens from different 
sources and for discovering new species. Moreover, this strategy can also be used by 
scientists with less technical expertise in taxonomy, and can be run from specimens that 
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2.  INTEREST AND OBJECTIVES 
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2.1  Interest of this work and objectives 
 
Recently, several studies have reported the increasing incidence of 
mucormycosis in both immunocompromised and immunocompetent patients (Bitar et 
al., 2009; Roden et al., 2005; Saegeman et al., 2010). Some species belonging to the 
order Mucorales (subphylum Mucoromycotina) are considered opportunistic pathogens, 
causing infections with a high mortality rate. Interesting is the epidemiological change 
observed in both Apophysomyces elegans and Saksenaea vasiformis, two species 
considered emerging pathogens, with a high clinical relevance in recent years, due to 
the infection in immunocompetent people. Additionally, several retrospective studies 
have been carried out, the largest and most comprehensive review to date being on 929 
cases of mucormycosis published by Roden and colleagues (2005) in which critical 
points like predisposing factors, clinical presentations, treatments, outcomes and 
etiological agents were analyzed. However, a high percentage of those 929 cases lacked 
identification to species level, and for most of them the identification was doubtful. In 
this way, the identification of the Mucorales remains a difficult, time-consuming task 
and demands trained personnel. 
Another relevant aspect is the fact that the Mucorales are resistant to most of the 
currently available antifungal drugs. Amphotericin B is the only antifungal drug to show 
potent in vitro activity and in vivo efficacy. Nevertheless, the clinical efficacy remains 
limited, with high mortality rate, especially when the infections are caused by either 
Saksenaea vasiformis or Apophysomyces elegans. 
Over the last few years, our laboratory has been working with the Fungus Testing 
Laboratory at the University of Texas, which is the reference center for the 
identification and antifungal susceptibility in the USA. We have been able to identify a 
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significant number of clinical isolates belonging to the Mucorales from several 
American hospitals. Also, since 1990, our laboratory has been using several molecular 
techniques for the study of pathogenic fungi, and having personnel trained in the 
identification of fungi has made the present study possible. 
This thesis aims to increase the knowledge of the taxonomy of some clinically 
important species of mucoralean fungi by studying those so far poorly explored aspects. 
The objectives of this thesis are the following: 
 
1. To assess the spectrum of mucoralean species and their frequency in clinical 
samples from the United States of America, and to try to establish the degree of 
correlation between morphological and molecular identification. 
 
2. To identify putative cryptic species using a polyphasic approach (i.e. DNA sequence 
data, morphology and physiology) in several genera so far poorly studied. 
 
3. Having identified and characterized the species involved in human infections, to 
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3.  MATERIALS  AND  METHODS 
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3.1 Origin of the isolates and storage 
A total of 217 isolates of species of Mucorales, from clinical and environmental 
samples, including types and reference strains obtained from different international 
culture collections and reference centers, were studied in the present work. Their 
geographic origin, substrates, or anatomical sites of isolation are detailed in sections 
4.1, 4.2, 4.3 and 4.4. 
All strains were conserved as submerged cultures in liquid paraffin or/and water. 
In the first procedure, fungi were cultured on potato dextrose agar (PDA; Pronadisa, 
Madrid, Spain) and potato carrot agar (PCA; 20 g potatoes, 20 g of carrot, 15 g of agar 
Pronadisa ref. 1800, 0.05 g de L-chloramphenicol Acofarma and 1 L distilled water) in 
slant tubes and the growing part of the agar covered by the liquid paraffin. The tubes 
were stored at room temperature. In the second procedure,  small pieces of sporulated 
cultures in Czapek agar (CZA; Difco, Becton Dickinson, France) and PDA were 
transferred to small dark vials (10 mL) containing 5 mL of distilled water and stored at 
room temperature. 
 
3.2 Phenotypic characterization 
The phenotypic characterization of the species included in the present thesis 
consisted in the study of their most relevant morphological features, both at macro- and 
microscopic level, the evaluation of their ability to assimilate carbon and nitrogen 
sources, and their growth response to different temperatures. In order to achieve the 
optimal growth and sporulation we tested different culture media. The morphological 
criteria used in the identification of the different taxa had been previously tested by 
other authors (de Hoog et al., 2000; Misra and Srivastava, 1979; Saksena, 1953; 
Schipper, 1973, 1975, 1976, 1978; Zycha et al., 1969).  
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 3.2.1.1 Colonies 
For morphological studies, a small inoculum of fungal colony was placed in the 
center of a petri dish (9 cm diameter), with each of the following culture media: Potato 
dextrose agar (PDA; Pronadisa, Madrid, Spain); Malt extract agar (MEA; 20 g malt 
extract, 15 g agar, 1 L of distilled water), and Czapek agar (CZA; Difco, Becton 
Dickinson, France). 
 
Cultures were incubated at 25ºC in darkness. Cultural characteristics were 
determined at 4-10 days after inoculation. Colony diameters, texture, colour (Kornerup 
and Wanscher, 1978), and production of exudates and pigments were evaluated. 
 
3.2.1.2 Microscopic features 
 The micromorphology of the isolates was determined performing slide cultures 
mounted in lactic acid or water, and examined using a light microscope Zeiss Axio 
Imager M1. The size, shape, ornamentation, and color of the following structures, when 
present, were studied and measured: 
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 sporangiospores  
 giants cells 
 septa 
 rhizoids  
 
 3.2.1.3 Electron microscopy  
Scanning electron microcopy techniques were used mainly for a detailed study 
of the ornamentation of several fungal structures but particularly for the surface of the 
sporangiospores which constitutes a relevant taxonomic character in Mucor. The 
methods used were based on Figueras and Guarro (1988). 
- Fixation. Small pieces of 5 x 5 mm were selected and transferred to vials 
containing to 2% glutaraldehyde solution in 0.1 M phosphate buffer (Sabatini et al., 
1963). To prevent the samples floating, several drops of Tween 80 were added (Carroll 
and Carroll, 1973). The vials were vacuum-dried for around 1 hour (Campbell, 1972; 
Hanlin, 1982; Rosing, 1982). Later, the samples were washed for 15 minutes in 0.1 M 
phosphate buffer. Next, a second fixation was performed with a 1% p/v osmium 
tetroxide solution (O4Os) in 0.1M phosphate buffer (Palade, 1952). 
- Dehydration. The samples were dehydrated through a graded series of 
aqueous ethanol solutions (30% v/v - 100% v/v). Later, the aqueous ethanol solutions 
were replaced by amyl acetate-ehtanol mixtures (amyl acetate-ethanol 1:3 v/v - amyl 
acetate). 
- Dry. The phase of critical point dry replaces the water present in the samples 
by CO2 (Anderson, 1953; Bartlet and Burstyn, 1975). 
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- Mount and coat. Once samples are dried, they were mounted on specimen 
stubs with colloidal silver, sputter-coated with gold-palladium in a Polaron Sputter 
Coater. 
- Observation. The samples were examined with a scanning electron 
microscope Jeol JSM-6400. 
 
3.2.2 Physiological tests 
For the identification of the isolates belonging to Apophysomyces, Mucor and 
Saksenaea the growth of such fungi on 2% MEA at 4, 15, 24, 30, 35, 37, 42, 45 and 50º 
C were determined in dark. Colony diameters were measured every 2 days to establish 
the growth rates. 
 Carbon sources assimilation patterns were determined with the commercial kit 
API 50CH (bioMérieux, Marcy-l’Etoile, France) according to the protocols described 
by Schwarz et al (2007). To obtain sufficient sporulation, all strains were cultured for 6 
days on CZA at 37ºC and 42ºC for the Saksenaea and Apophysomyces species 
respectively. A final concentration of 5 x 105 CFU/mL was prepared in 20 mL of yeast 
nitrogen base (7.7g/L; Difco), containing 0.5g/L-chloramphenicol (Sigma-Aldrich) and 
0.1% Bactoagar (Difco), and each well of the strips was inoculated with 300 µL of 
medium. The viability of the conidia was verified by plating 100 µL of serial dilutions 
of each inoculum onto PDA and incubating at 37/42 ºC for 6 days. The inoculated API 
50CH strips were incubated for 48–72 h at 37/42 ºC in dark. After incubation, the strips 
were read visually and growth or lack of growth was noted. Weak growth was 
considered as a positive result.  
Nitrogen source assimilations were determined using the same inoculum 
described above, but the yeast nitrogen base broth was replaced by carbon nitrogen base 
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broth (Difco), and testing was performed in sterile, disposable, multiwell microplates. 
The medium with the nitrogen sources was dispensed into the wells in 150 µL volumes 
with a multichannel pipette and each well was inoculated with 50 µL of the conidial 
suspension. The microplates were incubated at 37 ºC in dark for 48 and 72h. We also 
determined growth of the strains on NaCl (2%, 5%, 7%, 10%), MgCl2 2%, and 
cycloheximide 0.1% (de Hoog et al., 1994; Yarrow, 1998). All tests were performed in 
duplicate.  
The production of urease was determined after incubation on Christensen’s urea 
agar slants at 37 ºC for 8 days (de Hoog et al., 1994; Ghosh et al., 2002; Yarrow, 1998). 
In both studies, the final columns of the multiwell microplates were used as positive and 
negative controls respectively. The positive control consisted in 150 L of Bacto Yeast 
Nitrogen Base (Difco) with glucose. The negative control consisted in 150 L of base 
medium without carbon and nitrogen sources.  
 
3.3 Molecular studies  
DNA extraction was performed directly from fungal colonies on PDA after 5-7 
days of incubation at 25º C in dark. We followed the Fast DNA kit protocol (Bio 101, 
Inc., Joshua Way, Vista, California, USA) as described by the manufacturer. 
Amplification and sequencing of the 5.8S ribosomal RNA gene and the ITS 
region (internal transcribed spacers 1 and 2) (Fig. 6) were performed with the primer 
pair ITS5/ITS4 (Table 1) as described by White et al (1990). The D1/D2 domains of the 
28S rRNA gene (Fig. 6) were amplified and sequenced using primers NL1/NL4 (Table 
1) following the protocol of O`Donnell (1993). The Histone 3 (H3) (Fig. 7) and 
elongation factor (EF-1α) genes (Fig. 8) were amplified with primer pairs H3-1A/H3-
1B (Glass and Donaldson, 1995) and MEF-11/MEF-41 (Table 1) (O`Donnell et al., 
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2001), respectively, following the Ready-To-Go bead protocol (Amersham Bioscience, 
Freiburg, Germany) and using the amplification programs described by Gilgado et al 
(2007). PCR products were purified using a GFXTM PCR DNA kit (Pharmacia 
Biotech, Cerdanyola del Vallès, Spain) and stored at -20 C until sequencing. PCR 
products were sequenced by using the same primers employed for amplification and 
following the Taq DyeDeoxy Terminator cycle sequencing kit protocol (Applied 
Biosystems, Gouda, The Netherlands). DNA sequencing reaction mixtures were 
analyzed on a 310 DNA sequencer (Applied Biosystems). 
The software Autoassember version 1.40 (Applied Biosystems, Perkin Elmer 
Corp., Norwalk, Connecticutt, USA) and SeqMan (Lasergene, Madison, Wisconsin) 
were used to obtain consensus sequences from the complementary sequences of each 
isolate. BLAST searches (Altschul et al., 1990) were performed to compare data of the 
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Fig. 8: map of the EF-1α gene showing exons and introns. The arrows indicate the 
primers direction. 
 
Table 1: Primers used in the present study. 
Gene / region primer Sequence  (5`- 3`) Product size 
ITS ITS 5 GGAAGTAAAAGTCGTAACAAGG 650-750 bp 
 ITS 4 TCCTCCGCTTATTGATATGC  
D1/D2 domains 28S rDNA NL1 GCATATCAATAAGCGGAGGAAAAG 600-650 bp 
 NL4 GGTCCGTGTTTCAAGACGG  
Histone 3 H3-1A ACTAAGCAGACCGCCCGCAGG 350-400 bp 
 H3-1B GCGGGCGAGCTGGATGTCCTT  
Elongation factor 1α MEF-11 AAGAAGATTGGTTTCAACCC 400-450 bp 
 MEF-41 GCACCGATTTGACCAGGRTGG  
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3.3.1 Phylogenetic studies 
Nucleotide sequence alignments were performed with ClustalX version 1.81 
(Thompson et al., 1997), followed by manual adjustments with a text editor (Microsoft 
Word 2002). In some cases, before the visual correction, the alignments were checked 
with Gblocks version 0.91b (Castresana, 2000), to remove hypervariable regions. 
 
For the phylogenetic inference, the following methods were used: 
 
 Neighbor-joining (NJ): NJ analyses were performed in the MEGA 4.1 
computer program (Tamura et al., 2007), using the model Maximum Composite 
Likelihood (Tamura et al., 2004) with bootstrap analysis of 1000 replicates 
(Felsenstein, 1985). 
 
 Maximum parsimony (MP): phylogenetic inference to find the most 
parsimonious tree was performed in the PAUP (version 4.0b10) (Swofford, 
2001). Heuristic searches was performed with 100 replicates, with random 
sequence addition and tree bisection-reconnection branch swapping algorithms, 
collapsing zero-length branches and saving all minimal length trees. Gaps were 
treated as missing data. 
 
 Maximum likelihood (ML): trees were inferred by the PhyML (version 3.0) 
(Guindon and Gascuel, 2003), with a heuristic search based on 100 replicates, 
with random sequence addition and nearing neighbor interchange branch-
swapping algorithm. The bootstrap analysis was performed with 1000 replicates. 
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 Bayesian inference (BI): The bayesian analyses were performed in the 
MrBayes (version 3.1) computer program (Huelsenbeck and Ronquist, 2001), 
running 1.000.000 generations in four chains, saving the trees every 100 
generations. The 25% of the all trees obtained were used to construct a 50% 
majority-rule consensus tree. 
For the analyses of ML and BI, the best-fit models were selected by 
MrModeltest (Posada and Crandall, 1998). 
The sequences generated during our research were deposited in EMBL 
(http://www.ebi.ac.uk/embl/Submission/). 
 
3.4 Mating tests  
To evaluate the formation of sexual structures (zygospores) the isolates were 
grown on CZA plates at 37 ±1°C in the dark, after which they were paired in all 
combinations, including selfcrosses, on CZA. Each strain was streaked onto one-half of 
a CZA plate opposite the streak of another strain, allowing for a central zone of contact 
when the strains grew. Plates were incubated at 37 ±1°C and were examined 
macroscopically each week for as long as 4-6 months for the presence of zygospores. 
All tests were performed in duplicate. 
 
3.5 Antifungal susceptibility testing 
The antifungal susceptibility tests were performed for the species belonging to 
Apophysomyces, Mucor and Saksenaea, using pure powders of known potency. 
 A total of 9 antifungal drugs were tested. They were: amphotericin B (AMB; 
Sigma-Aldrich, Saint Quentin Fallavier, France), anidulafungin (ANI; Pfizer Inc., New 
Cork, NY, U.S.A), voriconazole (VRC; Pfizer Central Research, Sandwich, United 
UNIVERSITAT ROVIRA I VIRGILI 
TAXONOMY AND PHYLOGENY OF CLINICALLY IMPORTANT MUCORALEAN FUNGI 
Eduardo Álvarez Duarte 
DL: T-1721-2011 
Kingdom), itraconazole (ITC; Janssen-Cilag, Issy-les-Moulineaux, France), 
ravuconazole (RVC; Bristol-Myers Squibb Co., New Brunswick, NJ, U.S.A), 
caspofungin (CAS; Merck&Co., Inc., Rahway, NJ, U.S.A), posaconazole (PSC; 
Schering-Plough Ltda., Hertfordshire, United Kingdom, Schering-Plough Research 
Institute, Kenilworth, NJ, U.S.A, and Schering-Plough Europa, Brussels, Belgium), 
micafungin (MFG; Astellas Pharma, Osaka, Japan), and terbinafine (TER; Novartis 
Pharma AG, Basel, Switzerland). 
The isolates were subcultured on CZA for 7 to 20 days at 30°C or 37°C. 
Sporangiospores were then collected in water, and the suspension was adjusted to 2 x 
104 UFC5/mL per well. Antifungal susceptibility testing was performed by a broth 
microdilution technique according to the guidelines of the National Committee for 
Clinical Laboratory Standards M38-A (NCCLS, 2002), and M38A-2 (CLSI, 2008).  
The antifungal drugs were dissolved in dimethyl sulfoxide (DMSO, Panreac 
Química S.A., Barcelona, Spain), or in distilled water (MFG). Subsequently, the stocks 
solutions of antifungal drugs were serially diluted in DMSO, and then each drug 
concentration was diluted 1:50 in RPMI. Wells of 96-well microtiter plates were filled 
with 100 μL of each drug concentration. A drug-free well containing RPMI + 2% 
DMSO in the medium served as the growth control. Each well was inoculated with 100 
µL of conidial suspension diluted 1:50 in RPMI. With the aim to evaluate the viability, 
100 µL of the dilutions were transferred to PDA plates. The microtiter plates were 
incubated for 24-48 h at 35ºC in dark. The fungal growth was assessed visually at 48 h, 
and confirmed at 72 h with the aid of a concave mirror and graded according to NCCLS 
guidelines as follows: 4, no reduction in growth; 3, slight reduction in growth; 2, 
prominent reduction in growth; 1, slight growth; and 0, absence of visual growth 
compared with the growth in the drug-free well. 
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Spectrum of Zygomycete Species Identified in Clinically Significant
Specimens in the United StatesV†
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Several members of the order Mucorales (subphylum Mucoromycotina) are important agents of severe human
infections. The identification of these fungi by using standard mycologic methods is often difficult and time
consuming. Frequently, the etiological agent in clinical cases is reported either as a Mucor sp., which is not the
most frequent genus of zygomycetes, or only as a member of the Mucorales. For this reason, the actual spectrum
of species of zygomycetes and their incidences in the clinical setting is not well known. The goals of this study
were to compare the results of the molecular identification of an important set of clinical isolates, received in
a mycological reference center from different regions of the United States, with those obtained by using the
traditional morphological methods and to determine the spectrum of species involved. We tested 190 isolates
morphologically identified as zygomycetes by using sequencing of the internal transcribed spacer (ITS) region
of the ribosomal DNA. Molecular identification revealed that Rhizopus oryzae represented approximately half
(44.7%) of these isolates. The remainder was identified as Rhizopus microsporus (22.1%), Mucor circinelloides
(9.5%), Mycocladus corymbifer (formerly Absidia corymbifera) (5.3%), Rhizomucor pusillus (3.7%), Cunningha-
mella bertholletiae (3.2%), Mucor indicus (2.6%), Cunninghamella echinulata (1%), and Apophysomyces elegans
(0.5%). The most common anatomic sites for clinically significant zygomycetes, as determined by isolates sent
to the Fungus Testing Laboratory for identification and/or susceptibility testing and included in this study,
were the sinuses, lungs, and various cutaneous locations, at 25.8%, 26.8%, and 28%, respectively. These sites
represented approximately 80% of the isolates evaluated. A high level of correlation (92.6%) between morpho-
logical and molecular identifications was found.
Members of the subphylum Mucoromycotina (formerly 
Zygomycota) (10) are characterized by the production of a 
coenocitic mycelium and the formation of asexual spores (spo­
rangiospores) in a variety of fungal structures. A few are ho­
mothallic, forming zygospores in culture. They are distributed 
worldwide and are ubiquitous in soil and organic substrates. 
Roden et al. (23) reported a 70% increase in the number of 
cases of zygomycosis between 1940 and 2000. These infections 
were more frequently seen in neutropenic patients, transplant 
recipients, patients with hematological disease or diabetes mel­
litus, patients receiving deferoxamine therapy (9, 18, 21, 32, 
38), and intravenous drug users (17). The most common clin­
ical infections in order were rhino-orbito-cerebral, cutaneous, 
pulmonary, disseminated, and gastrointestinal manifestations 
(23). The most clinically important zygomycetes are in the 
order Mucorales, comprising approximately 60 genera, some of 
which are important etiologic agents of human disease, espe­
cially in immunocompromised patients (6). Rhizopus is the 
most common genus causing human infection, although other 
genera such as Mucor, Rhizomucor, Cunninghamella, Apophy­
somyces, and Mycocladus (formerly Absidia) have also been 
reported, although less frequently (6, 7, 21). 
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School, Universitat Rovira i Virgili, C/Sant Llorenç 21, 43201 Reus, 
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josep.guarro@urv.cat. 
† Supplemental material for this article may be found at http://jcm 
.asm.org/. 
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As has been demonstrated, pathogenic species of the zygo­
mycetes show important differences in their responses to anti­
fungal drugs (1, 31), and their correct identification in human 
infection is of prime importance (4). However, the etiologic 
agents of zygomycoses in numerous clinical cases are not iden­
tified to the species level or are more commonly being improp­
erly named Mucor spp. Routine laboratory tests commonly 
identify isolates only as a zygomycete or to the genus level at 
best. In the most comprehensive review of zygomycoses pub­
lished to date, a high percentage of the 929 cases reviewed 
lacked identification to the species level, and for most, the 
identification is doubtful (23). In recent years, it has been 
demonstrated that the analysis of DNA sequences, especially 
that of ribosomal DNA (rDNA), is very useful for the identi­
fication of zygomycetes (29, 36, 37). 
We have retrospectively analyzed a large number of human 
clinical isolates of zygomycetes preserved at the Fungus Test­
ing Laboratory in the Department of Pathology at the Univer­
sity of Texas Health Science Center at San Antonio. Given the 
difficulty of morphological identification, final identifications 
were reached after sequencing the internal transcribed spacer 
(ITS) region of the rDNA. 
MATERIALS AND METHODS
Fungal isolates. A total of 190 clinical isolates submitted to the Fungus Testing 
Laboratory at the University of Texas Health Science Center at San Antonio 
from the period of January 2001 to February 2007 were analyzed (see the 
supplemental material). In addition, the type or reference strains of Apophyso­
myces elegans, Cunninghamella bertholletiae, Cunninghamella echinulata, Mucor
circinelloides, Mucor hiemalis, Mucor indicus, Mucor racemosus, Mucor ramosis­
























pril 13, 2010 
1650 
UNIVERSITAT ROVIRA I VIRGILI 
TAXONOMY AND PHYLOGENY OF CLINICALLY IMPORTANT MUCORALEAN FUNGI 
Eduardo Álvarez Duarte 
DL: T-1721-2011 
VOL. 47, 2009 SPECTRUM OF ZYGOMYCETE SPP. IN U.S. CLINICAL SPECIMENS 1651
TABLE 1. Comparison of morphological and molecular identification of isolates examined
No. of isolates identified by molecular methods 















































































































Rhizopus oryzae 85 85 100 
Rhizopus microsporus 42 42 100 
Mucor circinelloides 18 18 100 
Mycocladus corymbifer 10 10 100 
Cunninghamella bertholletiae 6  3  9  66  
Rhizomucor pusillus 7 7 100 
Mucor indicus 5 1 6 83.3 
Apophysomyces elegans 4  1  5  20  
Mucor racemosus 3 3 0 
Mucor ramosissimus 3 3 0 
Cunninghamella echinulata 2 2 100 
Total 85 42 10 18  7  6  5  4  3  3  3  2  1  1  190  92.6 
a The results of the BLAST search showed 94 to 95% MLI with the Mucor circinelloides type strain CBS 195.68 and 97 to 99% MLI with a Mucor racemosus non-type 
strain (ATCC 1216B; AJ271061.1). In the phylogenetic tree (Fig. 2), the sequences of this species and of the Mucor racemosus type strain were rather distant. 
b The results of the BLAST search showed 95% MLI with the Mucor indicus type strain CBS 226.29. 
mucor variabilis var. regularior, Rhizopus microsporus, and Rhizopus oryzae were 
also included in the analysis. All isolates, including the reference strains, were 
subcultured onto plates containing potato dextrose agar (Pronadisa, Madrid, 
Spain) at room temperature (24°C : 2°C) for 2 to 5 days to ensure purity. 
Isolates were subsequently grown on potato dextrose agar slants for 7 days and 
later covered with mineral oil for long-term room temperature storage. 
Morphological identification. The isolates were identified using schemes based 
on morphological and physiological characters (6, 25–28, 40). Microscopic ob­
servation was made from slide preparations mounted in water and lactophenol, 
using a Leitz Dialux 20EB microscope. 
DNA extraction, amplification, and sequencing. DNA was extracted and pu­
rified directly from fungal colonies following the FastDNA kit protocol (Bio101, 
Vista, CA), with a minor modification consisting of a homogenization step 
repeated three times with a FastPrep FP120 instrument (Thermo Savant, Hol­
brook, NY). The DNA was quantified by GeneQuant pro (Amersham Pharmacia 
Biotech, Cambridge, England). The ITS region of the nuclear rDNA was am­
plified with the primer pair ITS5 and ITS4, following the protocol described by 
Gilgado et al. (8). 
The PCR mix (25 fl) included 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 2.5 mM 
MgCl2 (10X PerkinElmer buffer II plus MgCl2 solution; Roche Molecular Sys­
tems, Branchburg, NJ), 100 fM of each deoxynucleoside triphosphate (Promega, 
Madison, WI), 1 fM of each primer, and 1.5 U of AmpliTaq DNA polymerase 
(Roche). The amplification program included an initial denaturation at 94°C for 
5 min, followed by 35 cycles of denaturation at 95°C for 30 s, annealing for 1 min 
at 52°C, and extension for 1 min at 72°C. After PCR analysis, the products were 
purified with an illustra GFX PCR DNA and gel band purification kit (General 
Electric Healthcare, Buckinghamshire, United Kingdom) and stored at -20°C 
until they were used in sequencing. PCR products were sequenced by using the 
same primer used for amplification and following the Taq DyeDeoxy Terminator 
cycle sequencing kit protocol (Applied Biosystems, Gouda, The Netherlands). 
Reactions were run on a 310 DNA sequencer (Applied Biosystems). Consensus 
sequences were obtained using the AutoAssembler program (PerkinElmer-Ap­
plied Biosystems) and SeqMan software (Lasergene, Madison, WI) Multiple­
sequence alignments were performed with the ClustalX (version 1.8) computer 
program (35), followed by manual adjustments with a text editor. These products 
were analyzed on an ABI Prism 310 automated DNA analyzer (Applied Biosys­
tems). 
Phylogenetic analyses. The phylogenetic analyses were performed with the 
help of the software program MEGA 4.0 (33). The maximum composite likeli­
hood algorithm was used for the determination of evolutionary distances be­
tween sequences. Trees were built using the neighbor-joining (NJ) method. Gaps 
were treated as pairwise deletions. Support for internal branches was assessed by 
a search of 1,000 bootstrapped sets of data. The final identification of the isolates 
was performed using Basic Local Alignment Search Tool (BLAST) searches (2). 
Only the nucleotide sequences of type or reference strains, deposited in the 
GenBank/EMBL database, were considered for identification purposes. When 
the BLAST algorithm aligned and compared the sequences of our isolates with 
those considered confident, a maximal level of identity (MLI) equal to or higher 
than 98% was considered for specific identification. MLI values lower than 98% 
provided identification only to the genus level. 
Nucleotide sequence accession numbers. Sequences from one isolate identi­
fied as Mycocladus corymbifer (UTHSC 06-1655) and another identified as Rhi­
zopus microsporus var. oligosporus (UTHSC 03-3512) have been deposited in 
GenBank under accession numbers FN293105 and FN293106, respectively. 
RESULTS
The lengths of the amplicons of the ITS1-5.8S-ITS2 region 
in Rhizopus oryzae isolates varied from 530 to 550 bp; in R.
microsporus isolates, from 601 to 616 bp; in Mucor circinel­
loides, from 524 to 572 bp; in Mycocladus corymbifer, from 681 
to 700 bp; in Cunninghamella bertholletiae and a Cunningha­
mella sp., from 602 to 631 bp; in Mucor indicus, from 520 to 537 
bp; in Rhizomucor pusillus, from 526 to 529 bp; in Apophyso­
myces elegans and an Apophysomyces sp., 672 to 818 bp; in the 
other Mucor sp., from 524 to 572 bp; and in Cunninghamella
echinulata, from 770 to 810 bp. 
Table 1 shows the results of the molecular identification. A 
total of nine known species could be identified. In addition, 
two undescribed species of Mucor (called Mucor sp. strain 1 
and Mucor sp. strain 2), which were morphologically identified 
as Mucor ramosissimus and Mucor indicus, respectively, were 
also detected. The molecular study also revealed that not all 
the Apophysomyces isolates belong to a single species, but 
unfortunately the ITS sequence of the type strain of A. elegans
is not in GenBank and was not available for study. Lastly, 
molecular characterization also supports the possibility of 
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and C. bertholletiae. In order of frequency, the most prevalent 
agent of zygomycosis was Rhizopus oryzae, comprising nearly 
half of the isolates tested (44.7%), and this was followed by R.
microsporus (22.1%), Mucor circinelloides (9.5%), Mycocladus
corymbifer (5.3%), Rhizomucor pusillus (3.7%), Cunningha­
mella bertholletiae (3.2%), Mucor indicus (2.6%), Cunningha­
mella echinulata (1%), and Apophysomyces elegans (0.5%). 
Since only a total of 7.4% of the isolates could not be identified 
to the species level, the correlation between morphological and 
genetic methods at the species level was 92.6% and at the 
genus level it was 100%. The only discrepancies corresponded 
with those isolates that represented undescribed species. A 
listing of the anatomic sites for the isolates based upon the 
information available and cross-referenced by species is pro­
vided in Table 2. The majority of the isolates, approximately 
80%, were represented by isolates from the sinuses (25.8%), 
lungs (26.8%), and various cutaneous presentations (28%). 
The remaining 20% of the isolates consisted of a subset col­
lected from deep sites, such as the brain, bones, liver, bladder, 
blood, bowel, and heart as well as from a few miscellaneous 
sites and one isolate from a marine mammal. 
Figure 1 shows the NJ tree of the 5.8S rRNA genes of a 
representative number of the isolates treated in this study, 
including the type and reference strains of the species men­
tioned above. Due to the high level of variability in the se­
quences of the ITS regions, it was not possible to align them all 
with confidence. Therefore, in this analysis we used only se­
quences of the 5.8S rRNA gene. Six main clades, each sup­
ported by a high bootstrap value and representing a different 
genus (Mucor, Rhizopus, Mycocladus, Apophysomyces, Rhizo­
mucor, and Cunninghamella), were observed in the phyloge­
netic tree (Fig. 1). The different species of each genus were 
also well separated, with the exception of those belonging to 
the genus Mucor. To better determine the phylogenetic rela­
tionship among the species of the genus Mucor, a new analysis 
using the sequences of the ITS regions of the isolates of this 
genus was performed. The sequences of the type strains of 
Rhizomucor variabilis var. variabilis and Rhizomucor variabilis
var. regularior were also included to build an NJ tree (Fig. 2). 
In the ITS tree, the Mucor species were well separated in 
different clades, with each receiving a high level of statistical 
support. All the isolates of M. circinelloides and the type strain 
of Rhizomucor variabilis var. regularior were nested in a single 
clade. A total of 14 isolates could not be assigned to any known 
species. 
DISCUSSION
This study contains the largest number of clinical isolates of 
zygomycetes identified to the species level by molecular char­
acterization. Unfortunately, similar studies performed in other 
countries for comparison purposes do not exist. In the review 
of Roden et al. (23), the zygomycetes causing approximately 
half of the reported cases were identified by culture. However, 
that study was only a compilation of unrelated cases, with 
identifications performed in different institutions. In numerous 
cases, the mycological methods used were not described. 
Therefore, most of those identifications are considered doubt­
ful or of insufficient accuracy. Three recent retrospective stud­
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FIG. 1. NJ tree based on maximum composite likelihood-corrected nucleotide distances among 5.8S rRNA gene sequences of representative 
isolates of the species listed in Table 1. In the tree, branch lengths are proportional to distance. Bootstrap iteration frequencies (1,000 iterations) 
above 70% are indicated on the nodes. Type or reference strains are indicated in boldface. T, type strain; NT, neotype strain. 
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significant number of cases. However, one of these (30) distin­
guished only between Mucor spp. and Rhizopus spp., and in the 
others (13, 14) only the genus names were mentioned (Cun­
ninghamella, Mucor, Rhizopus, and Syncephalastrum). The elec­
tion of a cutoff score of :98% for the molecular identification 
of the isolates was based in the sequence variability observed 
within the species represented by well-supported clades (boot­
strap values, :80%) in the phylogenetic tree (Fig. 1). 
In this study, isolates from the sinuses and related areas 
(sino-orbital, sino-nasal, and hard palate) represented 25.8% 
of the isolates evaluated. Roden et al. (23) reported that sinus 
involvement, consisting of rhinocerebral, sinus, and sino-or­
bital infections, constituted the majority (66%) of infections in 
diabetic patients. 
The lungs and related sites were similarly represented at 
26.8%. Among all forms of zygomycosis, cutaneous infection is 
a less frequent presentation (3, 21), and it is associated with 
penetrating trauma, burns, motor vehicle accidents, and falls 
(23). In the present study, however, cutaneous sites accounted 
for 28% of the isolates, and the most prevalent agent was 
Rhizopus oryzae. 
The molecular identification of clinical zygomycetes using 
the ITS region has been successfully used in recent years (11, 
12, 19, 29, 36, 37, 39). However, a BLAST search can constitute 
an important limitation of such procedures when comparisons 
are made with inaccurate sequence data (5). In our case for the 
sequences of Mucor circinelloides, the BLAST search gave a 
similarity of 99 to 100% with the type strain of Rhizomucor
variabilis var. regularior. When we compared the sequences of 
the type strains of both species, we noticed that they were 
identical. Considering that in our phylogenetic tree the type 
species of Rhizomucor, Rhizomucor pusillus, was placed very far 
from the Mucor clade (Fig. 2), it seems logical to consider R.
variabilis var. regularior a synonym of Mucor circinelloides. 
Schwarz et al. (29) also previously reported a high level of 
similarity between the sequences of these two species. Rhizo­
mucor variabilis var. variabilis was also included in our study in 
the Mucor clade, in this case close to M. hiemalis. Voigt et al. 
(37), analyzing the 28S and 18S rDNA loci, also reported that 
R. variabilis var. variabilis was phylogenetically closely related 
to Mucor hiemalis and Mucor mucedo. The most important 
morphological feature reported in the literature to differenti­
ate Rhizomucor spp. from Mucor spp. is the presence of rudi­
mentary rhizoids in the former. However, this does not seem to 
be a very consistent taxonomic feature, since this study dem­
onstrated that the two varieties of R. variabilis, which have such 
rhizoids, belong to the genus Mucor. In addition, R. variabilis
shows several morphological features typical of Mucor spp., 
such as the size and type of sporangiospores, the presence of 
chlamydospores, the maximum temperature for growth, and 
other cultural characteristics. 
Infections by Rhizomucor spp. are rare in humans and are 
caused mostly by R. pusillus (11, 21). The sequences of the R.
pusillus isolates analyzed here were very similar, and they can 
be easily distinguished from those of other genera. These re­
sults agree with previous studies reported by different authors 
(11, 19, 29). 
In the present study, the ITS sequences of six isolates in­
cluded in the Mucor clade (Fig. 2) presented a very low level of 
similarity with the sequences of the species of Mucor deposited 
in GenBank. Three of these isolates showed identical se­
quences (Mucor sp. strain 1) and were distributed into one 
well-supported subclade. Initially they were morphologically 
identified as Mucor ramosissimus. However, the BLAST search 
showed a low percentage of similarity (94 to 95%) with the 
type strain of M. ramosissimus (CBS 135.65). The other three 
isolates, which had different sequences between them, were 
initially morphologically identified as Mucor racemosus. In this 
case, the BLAST search for these isolates also showed a low 
similarity (90 to 91%) with the type strain of M. racemosus
(CBS 260.68). Another isolate of Mucor that we could not 
identify to the species level was UTHSC 02-2090 (Mucor sp. 
strain 2). This isolate was phylogenetically and morphologically 
related to M. indicus isolates. It is of interest that two of the M.
indicus isolates were recovered from the liver, corroborating 
previous reports of this organism’s ability to disseminate, par­
ticularly in immunocompromised and/or neutropenic individ­
uals (34). One report of a bone marrow transplant recipient 
suggests that the organism may have been acquired following 
ingestion of naturopathic medicine containing the organism 
(20). 
In general, we found a high genetic variability in the 5.8S 
rRNA gene sequences of species from Cunninghamella and 
Apophysomyces. In the former genus, our analysis was able to 
clearly differentiate C. echinulata and C. bertholletiae. How­
ever, we were not able to identify to the species level the other 
three isolates with high percentages of similarity which were 
morphologically identified as C. bertholletiae. The most com­
mon and practically the sole species of the genus Cunningha­
mella that is traditionally considered the etiologic agent of 
human infections is C. bertholletiae (21, 24). However, Lemmer 
et al. (15) reported in Germany a case of human infection by 
C. echinulata which was identified by sequencing the ITS re­
gion. In that study, the isolates of C. echinulata from environ­
mental and clinical origins showed identical digestion patterns 
in the ITS restriction fragment length polymorphism by using 
TaqI and HinfI. Our study confirms the identification of C.
echinulata as a clinically significant isolate. In the Apophyso­
myces clade, although all the isolates included were morpho­
logically similar to A. elegans, the only species of the genus 
involved in human infections so far, a high level of molecular 
intraspecific variability was observed. Five of these isolates 
showed a low level of similarity (87 to 91%) with the sequence 
of a reference strain of A. elegans (AJ849363). Most of the 
Apophysomyces elegans infections reported have occurred in 
immunocompetent patients (16). In this study, the one isolate 
with 99% similarity to the reference strain was recovered from 
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FIG. 2. NJ tree based on maximum composite likelihood-corrected nucleotide distances among the ribosomal ITS regions and 5.8S rRNA gene 
sequences of the isolates included in the Mucor clade shown in Fig. 1. In the tree, branch lengths are proportional to distance. Bootstrap iteration 
frequencies (1,000 iterations) above 70% are indicated on the nodes. Type strains are indicated in boldface. T, type strain. 
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known aggressive and commonly systemic pathogen in killer 
whales (Orcinus orca), Pacific white-sided dolphins (Lageno­
rhynchus obliquidens), and bottlenose dolphins (Tursiops trun­
cates) (22). The other four morphologically similar human 
isolates occurred in one case of sino-orbital involvement and 
three cutaneous presentations (Table 2). 
In conclusion, although the identification of zygomycetes 
remains a difficult and time-consuming task, this study has 
demonstrated that morphological features alone, when as­
sessed by individuals with expertise in fungal identification, can 
provide a high level of accuracy and that ITS sequencing can be 
a useful tool in the identification of the most common clinically 
significant species of zygomycetes and the delineation of un­
described species. The most common species in this set of 
clinical isolates were Rhizopus oryzae and Rhizopus micros­
porus. 
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8. Gilgado, F., J. Cano, J. Gené, and J. Guarro. 2005. Molecular phylogeny of 
the Pseudallescheria boydii species complex: proposal of two new species. 
J. Clin. Microbiol. 43:4930–4942. 
9. Greenberg, R. N., L. J. Scott, H. H. Vaughn, and J. A. Ribes. 2004. Zygo­
mycosis (mucormycosis): emerging clinical importance and new treatments. 
Curr. Opin. Infect. Dis. 17:517–525. 
10. Hibbett, D. S., M. Binder, J. F. Bischoff, M. Blackwell, P. F. Cannon, O. E.
Eriksson, S. Huhndorf, T. James, P. M. Kirk, R. Lucking, H. Thorsten
Lumbsch, F. Lutzoni, P. B. Matheny, D. J. McLaughlin, M. J. Powell, S.
Redhead, C. L. Schoch, J. W. Spatafora, J. A. Stalpers, R. Vilgalys, M. C.
Aime, A. Aptroot, R. Bauer, D. Begerow, G. L. Benny, L. A. Castlebury, P. W.
Crous, Y. C. Dai, W. Gams, D. M. Geiser, G. W. Griffith, C. Gueidan, D. L.
Hawksworth, G. Hestmark, K. Hosaka, R. A. Humber, K. D. Hyde, J. E.
Ironside, U. Koljalg, C. P. Kurtzman, K. H. Larsson, R. Lichtwardt, J.
Longcore, J. Miadlikowska, A. Miller, J. M. Moncalvo, S. Mozley-Stan-
dridge, F. Oberwinkler, E. Parmasto, V. Reeb, J. D. Rogers, C. Roux, L.
Ryvarden, J. P. Sampaio, A. Schussler, J. Sugiyama, R. G. Thorn, L. Tibell,
W. A. Untereiner, C. Walker, Z. Wang, A. Weir, M. Weiss, M. M. White, K.
Winka, Y. J. Yao, and N. Zhang. 2007. A higher-level phylogenetic classifi­
cation of the fungi. Mycol. Res. 111:509–547. 
11. Iwen, P. C., A. G. Freifeld, L. Sigler, and S. R. Tarantolo. 2005. Molecular 
identification of Rhizomucor pusillus as a cause of sinus-orbital zygomycosis 
in a patient with acute myelogenous leukaemia. J. Clin. Microbiol. 43:5819– 
5821. 
12. Iwen, P. C., L. Sigler, R. K. Noel, and A. G. Freifeld. 2007. Mucor circinel­
loides was identified by molecular methods as a cause of primary cutaneous 
zygomycosis. J. Clin. Microbiol. 45:636–640. 
13. Kontoyiannis, D. P., M. S. Lionakis, R. G. Lewis, G. Chamilos, M. Healy, C.
Perego, A. Safdar, H. Kantarjian, R. Champlin, T. J. Walsh, and I. I. Raad.
2005. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus­
active antifungal therapy: a case-control observational study of 27 recent 
cases. J. Infect. Dis. 191:1350–1360. 
14. Kontoyiannis, D. P., V. C. Wessel, G. P. Bodey, and K. V. I. Rolston. 2000. 
J. CLIN. MICROBIOL. 
Zygomycosis in the 1990s in a tertiary-care cancer center. Clin. Infect. Dis. 
30:851–856. 
15. Lemmer, K., H. Losert, V. Rickerts, G. Just-Nübling, A. Sander, M. Kerk-
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Supplementary material. Table listing the source and molecular identification of the 
isolates studied  
 
# Source Isolates #
(UTHSC)
Molecular identification 
1 Right hand  01-11 Mucor circinelloides* 
2 Right cribiform 01-149 Rhizopus microsporus  
3 Face tissue 01-316 Rhizopus oryzae 
4 Stoma tissue 01-667 Mucor indicus 
5 Lung cavity 01-983 Rhizopus microsporus  
6 Slant-not provided 01-1164 Rhizopus microsporus  
7 Fine needle aspirate left upper lobe 01-1325 Rhizopus microsporus  
8 Arm tissue 01-1543 Rhizopus oryzae 
9 Sinus 01-1730 Rhizopus oryzae 
10 Tissue nasal tip 01-1944 Rhizomucor pusillus 
11 Lung tissue 01-1972 Rhizopus microsporus  
12 Hard palate 01-1985 Rhizopus microsporus  
13 Right maxillary sinus 01-2135 Rhizopus oryzae 
14 Sinus tissue 01-2181 Rhizopus oryzae 
15 Liver abscess 01-2203 Mucor indicus 
16 Ethmoid sinus 01-2258 Cunninghamella bertholletiae 
17 BAL 01-2276 Cunninghamella sp. 
18 Sputum 01-2298 Cunninghamella  echinulata 
19 Not provided 02-439 Rhizopus oryzae 
20 Right lower lobe tissue 02-651 Rhizopus oryzae 
21 Bronch wash 02-740 Rhizopus microsporus  
22 BAL 02-991 Rhizopus microsporus  
23 Central venous line site 02-1981 Mucor sp.1* 
24 Peritoneal dialysis fluid 02-2090 Mucor sp.2* 
25 Forearm 02-2126 Rhizopus microsporus  
26 Sputum 02-2365 Rhizopus oryzae 
27 Abdomen 02-2425 Rhizopus microsporus  
28 Hand wound 02-2453 Mucor indicus 
29 Left leg 02-2517 Rhizopus microsporus  
30 Lt. maxillary sinus 02-2882 Rhizopus oryzae 
31 Deep leg 03-112 Rhizopus oryzae 
32 Sinus 03-201 Mycocladus corymbifer 
33 Sputum 03-228 Rhizopus oryzae 
34 Hand tissue 03-285 Rhizopus oryzae 
35 Lower anterior leg tissue 03-299 Rhizopus oryzae 
36 Brain abscess 03-328 Mycocladus corymbifer 
37 Sinus 03-511 Rhizopus oryzae 
38 Tissue left middle meatus 03-547 Rhizopus oryzae 
39 Right leg tissue 03-757 Cunninghamella bertholletiae 
40 Blood 03-1044 Mucor spp.* 
41 Vascular catheter site 03-1161 Mucor circinelloides* 
42 Sputum 03-1544 Rhizopus microsporus 
43 Right lower lobe & left lower lobe 03-1802 Rhizopus microsporus 
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44 Bronchial 03-1823 Mucor spp.* 
45 BAL 03-1826 Rhizopus oryzae 
46 Bronchial 03-2032 Rhizopus oryzae 
47 Sputum 03-2241 Cunninghamella sp.* 
48 Liver abscess 03-2256 Mucor indicus 
49 Left ethmoid 03-2399 Rhizopus microsporus 
50 Not provided 03-2426 Rhizomucor pusillus 
51 Left forearm 03-2548 Rhizopus oryzae 
52 Tissue right upper lobe 03-2702 Rhizopus oryzae 
53 Sinus 03-2771 Rhizopus oryzae 
54 Arm skin 03-2869 Rhizopus microsporus  
55 Forearm 03-2919 Mucor circinelloides* 
56 Forearm 03-2970 Rhizopus oryzae 
57 Skin biopsy 03-3062 Mucor circinelloides* 
58 Nasal tissue 03-3110 Rhizopus oryzae 
59 Forearm 03-3165 Rhizopus oryzae 
60 Sputum 03-3298 Rhizopus oryzae 
61 Sinus 03-3348 Rhizopus oryzae 
62 Pleural fluid 03-3512 Rhizopus microsporus 
63 Tissue-dolphin 03-1234 Apophysomyces elegans 
64 Flank lesion 03-3725 Cunninghamella echinulata 
65 Finger 04-161 Rhizopus oryzae 
66 Tissue right orbit 04-278 Rhizopus oryzae 
67 Sinus 04-287 Mucor circinelloides* 
68 Nasal 04-374 Rhizopus oryzae 
69 Right nasal contents 04-393 Rhizopus oryzae 
70 Left ethmoid sinus 04-443 Rhizopus oryzae 
71 Ethmoid sinus 04-534 Mucor circinelloides* 
72 Pleural fluid 04-604 Rhizopus microsporus  
73 Tissue occipital lobe 04-636 Cunninghamella bertholletiae 
74 Left leg 04-838 Apophysomyces sp.* 
75 Right sinus 04-891 Apophysomyces sp.* 
76 Urine 04-1075 Rhizopus microsporus  
77 Bronchial 04-1199 Rhizopus microsporus 
78 Tissue 04-1220 Rhizopus oryzae 
79 Bronchial 04-1241 Rhizopus oryzae 
80 Sternal wound 04-1243 Mucor circinelloides* 
81 Cheek tissue 04-1567 Rhizopus oryzae 
82 Tissue right hand 04-1613 Rhizopus oryzae 
83 Right leg tissue 04-1848 Rhizopus oryzae 
84 Blood 04-1961 Mucor sp.1* 
85 Blood 04-1988 Mucor circinelloides* 
86 Sputum 04-2044 Mucor circinelloides* 
87 Nasal mass 04-2159 Rhizopus oryzae 
88 Tracheal 04-2314 Mycocladus corymbifer 
89 Nasal 04-2328 Rhizopus oryzae 
90 Tissue right upper lobe 04-2375 Rhizomucor pusillus 
91 Not provided 04-2459 Rhizopus oryzae 
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92 Rt. thigh 04-2492 Mucor spp.* 
93 Bronchial 04-2581 Cunninghamella bertholletiae. 
94 Hard palate 04-2602 Rhizopus oryzae 
95 Sinus tissue 04-2829 Rhizopus oryzae 
96 Nasal 04-3109 Rhizopus oryzae 
97 Pleural fluid 04-3292 Mycocladus corymbifer 
98 BAL 04-3294 Rhizopus microsporus 
99 Back 04-3360 Rhizopus microsporus  
100 Maxillary sinus 05-114 Rhizopus oryzae 
101 Tissue 05-146 Rhizopus oryzae 
102 Foot 05-197 Rhizopus oryzae 
103 BAL & skin 05-458 Mucor circinelloides* 
104 Sputum 05-596 Rhizopus microsporus  
105 Face biopsy 05-641 Mycocladus corymbifer 
106 Abdominal 05-707 Mucor circinelloides* 
107 Right sphenoid 05-791 Rhizopus microsporus  
108 Bladder 05-812 Rhizopus oryzae 
109 Rt. elbow 05-937 Rhizopus microsporus 
110 Soft tissue lt. axilla 05-1052 Rhizopus microsporus  
111 Tibial bone 05-1078 Mucor circinelloides* 
112 Skin Bx. 05-1085 Mucor circinelloides* 
113 Lung abscess 05-1147 Rhizopus microsporus  
114 Left knee 05-1312 Rhizopus microsporus  
115 Tissue left orbit 05-1502 Rhizopus oryzae 
116 Rt. lung 05-1582 Mycocladus corymbifer 
117 Abscess 05-1679 Rhizopus oryzae 
118 Not provided 05-1817 Rhizopus oryzae 
119 Left upper lobe lung tissue 05-1850 Rhizopus microsporus 
120 Rt.  maxillary sinus 05-2130 Cunninghamella sp.* 
121 Not provided 05-2275 Cunninghamella bertholletiae 
122 Sinus 05-2447 Rhizopus oryzae 
123 BAL 05-2501 Rhizopus microsporus  
124 Tissue left hand 05-2658 Rhizopus oryzae 
125 Tissue left sinus 05-2687 Mucor circinelloides* 
126 Tissue left forearm 05-2827 Rhizopus oryzae 
127 Sputum 05-2975 Rhizopus oryzae 
128 Forearm 05-2985 Rhizomucor pusillus 
129 Leg tissue 05-3032 Rhizopus oryzae 
130 Right knee 05-3111 Rhizopus oryzae 
131 Nasal 05-3132 Rhizopus oryzae 
132 Not provided 05-3221 Mucor circinelloides* 
133 Mid small bowel 05-3226 Rhizopus oryzae 
134 Right hip 05-3474 Rhizopus oryzae 
135 Wound 05-3479 Rhizopus oryzae 
136 Middle turbinate tissue 05-3580 Rhizopus oryzae 
137 Gingiva 06-26 Mycocladus corymbifer 
138 Palate tissue 06-89 Rhizopus oryzae 
139 Bronchial 06-195 Rhizopus microsporus  
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140 Lt. lung 06-229 Rhizopus microsporus  
141 Wound right lower leg 06-306 Rhizopus microsporus  
142 Sinus 06-329 Rhizopus oryzae 
143 Sinus wash 06-731 Rhizopus oryzae 
144 Bx. tissue 06-1080 Rhizopus oryzae 
145 Tissue 06-1143 Rhizopus oryzae 
146 Induced sputum 06-1227 Rhizomucor pusillus 
147 Sinus 06-1301 Rhizopus oryzae 
148 Penis tissue 06-1351 Rhizopus oryzae 
149 Nasal 06-1370 Mucor circinelloides* 
150 Blood 06-1655 Mycocladus corymbifer 
151 Blood 06-1667 Mucor sp.1* 
152 Rt. Heart ventricle 06-1670 Mycocladus corymbifer 
153 Sputum 06-1844 Rhizopus microsporus  
154 Lung tissue 06-1945 Cunninghamella bertholletiae 
155 Cheek tissue 06-2013 Rhizopus oryzae 
156 Forearm 06-2251 Rhizopus oryzae 
157 Arm 06-2374 Rhizopus oryzae 
158 Tissue right upper lobe 06-2413 Rhizomucor pusillus 
159 Right elbow 06-2457 Rhizopus oryzae 
160 Sputum 06-2588 Rhizopus microsporus  
161 Peritoneal 06-2713 Mucor indicus 
162 Right parietal 06-2714 Rhizomucor pusillus 
163 Sinus tissue 06-2868 Rhizopus oryzae 
164 Skin biopsy 06-2926 Rhizopus oryzae 
165 Abdomen 06-3264 Rhizopus oryzae 
166 Lung aspirate 06- 3126 Rhizopus microsporus  
167 Tissue 06-3684 Rhizopus microsporus  
168 Not provided 06-3784 Mucor circinelloides* 
169 Left ethmoid sinus 06-3827 Rhizopus oryzae 
170 Not provided 06-3848 Rhizopus microsporus  
171 Sinus 06-3849 Rhizopus oryzae 
172 BAL lingual 06-3913 Rhizopus oryzae 
173 Tissue chest 06-4012 Rhizopus microsporus  
174 Nasal 06-4035 Rhizopus oryzae 
175 Lt. lung 06-4133 Rhizopus oryzae 
176 Lung tissue 06-4152 Rhizopus oryzae 
177 Lt maxillary sinus 06-4282 Mycocladus corymbifer 
178 Wound 06-4336 Rhizopus oryzae 
179 Pleural fluid 06-4399 Rhizopus oryzae 
180 Sputum 06-4430 Rhizopus microsporus  
181 Right cheek 06-4434 Rhizopus oryzae 
182 Facial 07-204 Apophysomyces sp.* 
183 Nephrostomy urine 07-238 Rhizopus oryzae 
184 Maxillary sinus 07-365 Rhizopus oryzae 
185 Vertebral 07-371 Rhizopus microsporus  
186 Tracheal 07-389 Rhizopus microsporus  
187 Not provided R-3316 Mucor circinelloides* 
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188 Not provided R-3466 Rhizopus microsporus  
189 Left maxilla R-3556 Rhizopus microsporus  
190 Necrotic face tissue R-3841 Apophysomyces sp.* 
 
 Mucor sp.1*  The results of the BLAST search showed 94-95 % of maximum level of identity 
with the strain CBS 195.68 (type strain) of Mucor circinelloides and 97-99 % with a non–type 
strain of Mucor racemosus (ATCC1216B, AJ271061.1). In the phylogenetic tree, the 
sequence of this species and that of the type strain of Mucor racemosus were rather distant. 
 
 Mucor sp.2*  The results of the BLAST search showed 95 % of maximum level of identity  
with the strain CBS 226.29 (type strain) of Mucor indicus 
 
 Mucor spp*  The results of the BLAST search showed 94-95 % of maximum level of identity 
with the strain CBS 195.68 (type strain) of Mucor circinelloides and 98-99 % with a non–type 
strain of Mucor ramosissimus (UWFP 969, AY213664.1). In the phylogenetic tree, the 
sequence of this species and that of the type strain of Mucor ramosissimus were rather distant. 
 
 Mucor circinelloides* The percentages of homology in the BLAST search of these strains 
with the type strain of Mucor circinelloides were 98 – 100 %. This seems to demonstrate that 
this latter specie is a synonym of Mucor circinelloides. 
 
 Apophysomyces sp.*  The results of the BLAST search showed 87-91 % of maximum level of 
identity with the Kw1303 (GenBank # AJ849363) of Apophysomyces elegans. 
 
 Cunninghamella sp.*  The results of the BLAST search showed 87-96 % of maximum level of 
identity with the CBS 693.68 (GenBank # AF254931) of Cunninghamella bertholletiae. 
UNIVERSITAT ROVIRA I VIRGILI 
TAXONOMY AND PHYLOGENY OF CLINICALLY IMPORTANT MUCORALEAN FUNGI 
















4.2 Two new species of Mucor from clinical samples 
 
E. Alvarez, J. Cano, A. Stchigel, D. A. Sutton, A. W. Fothergill, V. Salas, M. G. Rinaldi, and J. Guarro 
 
Medical Mycology (2011) 49, 62–71 
UNIVERSITAT ROVIRA I VIRGILI 
TAXONOMY AND PHYLOGENY OF CLINICALLY IMPORTANT MUCORALEAN FUNGI 
Eduardo Álvarez Duarte 
DL: T-1721-2011 
 
UNIVERSITAT ROVIRA I VIRGILI 
TAXONOMY AND PHYLOGENY OF CLINICALLY IMPORTANT MUCORALEAN FUNGI 
Eduardo Álvarez Duarte 
DL: T-1721-2011 
 Received  11  March  2010 ; Receive
Accepted  5  June  2010 
 Correspondence: Josep Cano, U
Medicina i Ci è ncies de la Salut, 
LLoren ç 21, 43201-Reus, Tarrag
fax:   34 977 759322; E-mail: jose
 Two new species of Mucor from clinical samples 
 EDUARDO  ÁLVAREZ * ,  JOSEP  CANO * ,  ALBERTO M.  STCHIGEL * ,  DEANNA A.  SUTTON  † , 
 ANNETTE W.  FOTHERGILL  †  ,  VALENTINA  SALAS * ,  MICHAEL G.  RINALDI  †  &  JOSEP  GUARRO *  
  *  Mycology Unit, Medical School, IISPV, Universitat Rovira i Virgili, Reus, Spain, and   †  Fungus Testing Laboratory, University of Texas 
Health Science Center, San Antonio, Texas, USA 
© 2011 ISHAM 























































UNIVERSITAT ROVIRA I VIRGILI 
TAXONOMY AND PHYLOGENY OF CLINICALLY IMPORTANT MUCORALEAN FUNGI 
Eduardo Álvarez Duarte 
DL: T-1721-2011  Two new species in the order Mucorales,  Mucor velutinosus and  Mucor ellipsoideus , 
isolated from human clinical specimens in the USA, are described and illustrated. The 
former species is similar to  Mucor ramosissimus , from which it can be differentiated by 
its ability to grow at 37 ° C and produce verrucose sporangiospores.  Mucor ellipsoideus is 
also able to grow and sporulate at 37 ° C like  M. indicus , the nearest phylogenetic species 
in this study, however, the former has narrow ellipsoidal sporangiospores in contrast to 
the subglobose to ellipsoidal sporangiospores of  M. indicus . Analysis of the sequences 
of the ITS and the D1 – D2 regions of the rRNA genes confi rmed the novelty of these spe-
cies. The  in vitro antifungal susceptibility of the new species showed that amphotericin B 
was active against all isolates and posaconazole and itraconazole showed low activity. 
 Keywords  Mucor ,  Mucorales ,  mucormycosis ,  zygomycetes  Introduction 
 The phylum Zygomycota is an artifi cial assemblage of 
fungi of uncertain taxonomic position. Most of the genera 
of this phylum are currently included in the subphylum 
Mucoromycotina [1],  Mucor being the genus with the 
highest number of species. Molecular studies have demon-
strated that  Mucor is a polyphyletic genus [2]. Members 
of  Mucor are characterized by fast-growing colonies, 
simple or branched sporangiophores without basal rhizoids, 
non-apophysate sporangia, and zygospores having more 
or less equal, opposed, non-appendaged suspensors [3 – 5]. 
Several species of  Mucor have important biotechnological 
applications, and are used in the elaboration of different 
kinds of Asian food [6 – 8].  Mucor is, after  Rhizopus , the 
most clinically relevant genus of the Mucorales [9,10]. 
The species most frequently involved in human infections 
are  Mucor circinelloides ,  Mucor indicus ,  Mucor racemosus 
and  Mucor ramosissimus [3,9]. 
 In a recent phylogenetic study of mucoralean species 
from the US, where a wide panel of clinical isolates were 
included, some isolates of  Mucor could not be properly d in fi nal revised form 24 May 2010; 
nitat de Microbiologia, Facultat de 
Universitat Rovira i Virgili, C/ Sant 
ona, Spain. Tel:   34 977 759350; 
p.cano@urv.cat identifi ed at the species level. These isolates showed 
important distinctive morphological characters and were 
resolved into two well-supported phylogenetic clades 
( Mucor sp. 1 and  Mucor sp. 2) [9]. In the present study 
we have demonstrated that these two clades represent 
two new species of  Mucor which are described and illus-
trated here. 
 Materials and methods 
 Fungal isolates 
 A total of seven clinical isolates of  Mucor , which could not 
be identifi ed previously [9], are included in the present 
study. Three of these isolates were designed as  Mucor 
sp. 1, a fourth isolate as  Mucor sp. 2 and the other three 
were unnamed. The type or reference strains of the most 
clinically relevant species of the genus and some strains of 
species morphologically related to some of these isolates, 
such as  Mucor fragilis and  Mucor fuscus , were also 
included in this study (Table 1). All isolates were subcul-
tured on potato dextrose agar (PDA, Pronadisa, Madrid, 
Spain) at room temperature (25 ° C) for 2 – 5 days. 
 DNA extraction, amplifi cation and sequencing 
 DNA was extracted and purifi ed directly from fungal colo-
nies following the Fast DNA kit protocol (Bio101, Vista, 
Calif., USA), with a minor modifi cation, consisting of a DOI: 10.3109/13693786.2010.499521
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Table 1 Isolates included in the study and their origins.
GenBank accession nº
Isolate Species Source ITS 28S rDNA
UTHSC 03-1044 Mucor sp. Blood, Utah, USA FN650648 FN650661
UTHSC 03-1823 Mucor sp. Bronchial, Indiana, USA FN650649 FN650662
UTHSC 04-2492 Mucor sp. Right thigh, Minnesota, USA FN650651 FN650663
UTHSC 02-1981 Mucor sp. 1 Central venous line, Connecticut, USA FN650646 FN650672
UTHSC 06-1667 Mucor sp. 1 Blood, Minnesota, USA FN650652 FN650656
UTHSC 04-1961 Mucor sp. 1 Blood, New York, USA FN650650 FN650657
UTHSC 02-2090 Mucor sp. 2 Peritoneal dialysis fl uid, Florida, USA FN650647 FN650660
UTHSC 03-2919 Mucor circinelloides f. circinelloides Forearm, Minnesota, USA FN663959 n.d
UTHSC 05-3221 Mucor circinelloides f. circinelloides Colorado, USA FN663960 n.d
UTHSC 06-3784 Mucor circinelloides f. circinelloides Utah, USA FN663961 n.d
CBS 195.68NT Mucor circinelloides f. circinelloides Environment, air, The Netherlands FN650639 FN650667
CBS 384.95 Mucor circinelloides f. circinelloides Face, China FN663957 FN663953
CBS 108.17 Mucor circinelloides f. lusitanicus Unknown FN650644 FN650664
CBS 108.19 Mucor circinelloides f. lusitanicus Unknown FN650645 FN650665
CBS 236.35 Mucor fragilis Tremella, Hann.-Münden, Germany FN650655 FN650671
CBS 132.22T Mucor fuscus Unknown FN650653 FN650658
CBS 230.29 Mucor fuscus France FN650654 FN650659
CBS 201.65NT Mucor hiemalis f. hiemalis Michigan, USA FN650640 FN650668
CBS 226.29T Mucor indicus Switzerland FN650641 FN650669
UTHSC 01-667 Mucor indicus Stoma tissue, Pennsylvania, USA FN663955 n.d
UTHSC 02-2453 Mucor indicus Hand wound, Rhode Island, USA FN663956 n.d
CBS 260.68T Mucor racemosus Switzerland FN650642 FN650670
CBS 135.65NT Mucor ramosissimus Nasal lesion, Uruguay FN650643 FN650666
CBS 103.93T Rhizomucor variabilis var. variabilis Man, China FN663958 FN663954
CBS-KNAW, Centraalbureau voor Schimmelcultures, Utrecht, the Netherlands; UTHSC, Fungus Testing Laboratory, University of Texas Health Science 
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FP120 instrument (Thermo Savant, Holbrook, NY, USA). 
DNA was quantifi ed by the GeneQuant pro (Amersham 
Pharmacia Biotech, Cambridge, England). The internal 
transcribed spacer (ITS) region of the nuclear rRNA gene 
was amplifi ed with the primer pair ITS5 and ITS4 [11] and 
the D1-D2 domains of 28S rRNA gene were amplifi ed with 
the primer pair NL1-NL4 [12]. 
 The PCR mix (25  μ l) included 10 mM Tris-HCl 
(pH 8.3), 50 mM KCl and 2.5 mM MgCl 2 (10X Perkin-
Elmer buffer II plus MgCl 2 solution Roche Molecular 
Systems, Branchburg, NJ, USA), 100  μ M each dNTP 
(Promega, Madison, Wis, USA), 1  μ M of each primer and 
1.5 U of Ampli Taq DNA polymerase (Roche). The ampli-
fi cation program included an initial denaturation at 94 ° C 
for 5 min, followed by 35 cycles of denaturation at 95 ° C 
for 30 s, annealing for 1 min at 55 ° C, and extension for 1 
min at 72 ° C. After PCR, the products were purifi ed with 
an Illustra GFX ™ PCR DNA and Gel Band Purifi cation 
Kit (General Electric Healthcare, Buckinghamshire, UK) 
and stored at  – 20 ° C until they were used in sequencing. 
PCR products were sequenced by using the same primers 
used for amplifi cation and following the  Taq DyeDeoxy 
Terminator Cycle Sequencing Kit protocol (Applied Bio-
systems, Gouda, The Netherlands). Reactions were run on 
a 310 DNA sequencer (Applied Biosystems). Consensus 
sequences were obtained using the Autoassembler program © 2011 ISHAM, Medical Mycology, 49, 62–72(PerkinElmer-Applied Biosystems) and Seqman software 
(Lasergene, Madison, Wis.). Some sequences, correspond-
ing to several species of  Mucor , which could be related to 
our clinical isolates , or other genera of the Mucorales 
which were phylogenetically related to  Mucor in previous 
studies [2], were retrieved from GenBank and included in 
the phylogenetic study. 
 Phylogenetic analyses 
 Clustal X 1.8 was used to align the sequences, followed by 
manual adjustments with a text editor. For the individual 
analysis of the genes we used the software program MEGA 
4.0. The maximum composite likelihood algorithm was 
used for the determination of evolutionary distances 
between sequences. Trees were generated using the neigh-
bor-joining (NJ) method. Gaps were treated by the pairwise 
deletion option of MEGA. Support for internal branches was 
assessed by a search of 1000 bootstrapped sets of data. 
 Phenotypic studies 
 Isolates were cultured on PDA, Czapek agar (CZA; Difco, 
Becton Dickinson, France) and malt extract agar (MEA; 
10 g of malt extract, 20 g of agar, and 1000 ml of distilled 
water), incubated at 25 ° C in darkness, and examined daily. 
Color notations in parentheses are from Kornerup and 
Wanscher [13]. Microscopic features were determined in 
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a Zeiss Axio Imager M1 light microscope. Scanning electron 
microscope (SEM) micrographs were obtained with a Jeol 
JSM- 6400 scanning electron microscope using techniques 
described previously by Figueras and Guarro [14]. All iso-
lates were characterized morphologically following tradi-
tional criteria [3 – 5,15 – 17]. Growth rates of the isolates at 
different temperatures (4, 15, 25, 30, 37, 42, 45 and 50 ° C) 
were determined on 90 mm diameter PDA Petri dishes that 
had been inoculated at the center, and the colony diameters 
(in mm) were measured daily for up to 10 days. 
 Antifungal susceptibility 
 The  in vitro activity of amphotericin B (USP, Rockville, 
MD, USA), posaconazole (Schering-Plough Europe, 
Brussels, Belgium) and itraconazole (Janssen Pharmaceu-
tica, Beerse, Belgium) against the seven clinical isolates 
was evaluated following a microdilution reference method 
(M38-A2) [18]. 
 Nucleotide sequence accession numbers 
 Sequences of the ITS region and D1-D2 domains of the 
28S rRNA gene of the isolates listed in Table 1 were depos-
ited in GenBank. Accession numbers are shown in the 
same table. 
 Results 
 Phylogenetic analyses 
 With the primers used, the lengths of the amplicons of the 
ITS regions and D1 – D2 domains of the 28S rRNA gene 
were 530 – 572 bp and 576 – 658 bp, respectively. The phy-
logenetic tree inferred from NJ analysis of the nucleotide 
sequences of the ITS (Fig. 1) revealed that  Mucor sp. 1 
and  Mucor sp. 2 were located in two well supported 
clades. The three isolates of  Mucor sp. 1 constituted a 
highly supported branch (100% bootstrap support (bs)) 
within the biggest clade (96% bs), where also were placed 
 Mucor  circinelloides f.  circinelloides , M.  circinelloides f. 
 lusitanicus ,  M. fragilis , M. plumbeus ,  M. racemosus and 
M. ramosissimus , and the clinical isolates UTHSC 03-1823, 
UTHSC 03-1044 and 04-2492. Isolates UTHSC 03-1823 
and UTHSC 03-1044 were genetically very close to refer-
ence strains of  M.  circinelloides f.  lusitanicus and to 
the sequence EU484227 deposited in GenBank. Isolate 
UTHSC 04-2492 was nested with a reference strain 
(CBS 236.35) of  M. fragilis but two sequences retrieved 
from GenBank (EU862184 and EU484238), deposited as 
 M. fragilis , were clearly separated from them. The isolate 
of  Mucor sp. 2 was nested in a very distant clade (94% bs) 
together with  M. amphibiorum and  M. indicus , but clearly separated from these species. With this marker, the species 
of  Mucor phylogenetically more distant were  Mucor 
fl avus and  M. hiemalis , the latter forming a clade with the 
type of  Rhizomucor variabilis var.  variabilis . Species of 
several genera which other authors [2] reported previously 
as closely related to  Mucor , such as  Actinomucor elegans 
and  Parasitella parasitica were more separated. 
 The phylogenetic tree inferred from analyses of the 
D1 – D2 domains of the 28S rRNA gene (Fig. 2) possessed 
a topology similar to that of the ITS tree. The seven clini-
cal isolates investigated in this study showed similar genetic 
relationships to that in Fig. 1. 
 Phenotypic analyses 
 The minimum, optimal and maximum growth temperatures 
of the isolates of  Mucor sp. 1 were 7 ° C, 25 ° C and 37 ° C, 
respectively. These isolates grew well on all media tested, 
producing greyish velvety colonies. Microscopically, their 
sporangiophores were mostly sympodially branched, and 
the sporangiospores were globose to subglobose, thick-
walled and verrucose. The isolate of  Mucor sp. 2 also had 
a minimum, optimal and maximum growth temperatures of 
7 ° C, 25 ° C and 37 ° C, respectively, but formed white to pale 
yellow colonies in all media tested. Microscopically, the 
sporangiophores were simple or sympodially branched, and 
the sporangiospores were narrowly ellipsoidal, and thick- 
and smooth-walled. The minimum, optimal and maxi-
mum growth temperatures of the clinical isolates UTHSC 
03-1823, UTHSC 03-1044 and UTHSC 04-2492 of  Mucor 
sp. were 15 ° C, 25 ° C and 37 ° C, respectively. Microscopic 
features of these three isolates were similar, i.e. their spo-
rangiophores were sympodially branched, and the sporan-
giospores were very variable in shape (ovoid, ellipsoidal, 
subspherical or irregular), and thin- and smooth-walled. 
 Antifungal susceptibility 
 The minimal inhibitory concentrations of the antifungal 
drugs tested are shown in Table 2. Amphotericin B was 
active against all isolates. Posaconazole and itraconazole 
demonstrated low activity. 
 Based on the molecular and phenotypic results, we pro-
pose  Mucor sp. 1 and  Mucor sp. 2 as the following new 
species. 
 Mucor velutinosus  E.  Á lvarez, Stchigel, Cano, D. A. 
Sutton  & Guarro, sp. nov. (Fig. 3A – D; Fig. 4; Fig. 5) 
   Mucor sp. 1 sensu  Á lvarez  et al .  J Clin Microbiol 
2009;  47 : 1650 – 1656. 
 Ad 25 ° C in agaro cum decocto malturorum (MEA) 
coloniae velutinosae, 0.5 – 2 mm altae, Petri-patellas in die 
quarto, primum albae, cito cinerea (M.1E1), in adversum 
albidum. Sporangiophora erecta, simplicia et simpodialiter © 2011 ISHAM, Medical Mycology, 49, 62–72
© 2011 ISHAM, Medical Mycology, 49, 62–72
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M. lusitanicus
CBS 135.65NT Mucor ramosissimus
CBS 108.17T Mucor circinelloides f. lusitanicus
UTHSC 03-1823
CBS 108.19 Mucor circinelloides f. lusitanicus
UTHSC 03-1044
EU484227 Mucor circinelloides f. lusitanicus




UTHSC 02-1981 Mucor sp. 1
UTHSC 06-1667 Mucor sp. 1
UTHSC 04-1961 Mucor sp. 1
UTHSC 05-3221 Mucor circinelloides f. circinelloides
CBS 384.95 Mucor circinelloides f. circinelloides
FJ455872 Mucor circinelloides f. circinelloides
UTHSC 03-2919 Mucor circinelloides f. circinelloides
UTHSC 06-3784 Mucor circinelloides f. circinelloides
CBS 195.68NT Mucor circinelloides f. circinelloides
FJ455870 Mucor circinelloides f. circinelloides
AF412290 Mucor plumbeus




CBS 132.22T Mucor fuscus
CBS 230.29 Mucor fuscus
AF412289 Mucor mucedo
FJ455860 Mucor amphibiorum
UTHSC 02-2090 Mucor sp. 2
UTHSC 02-2453 Mucor indicus
CBS 226.29T Mucor indicus
UTHSC 01-667 Mucor indicus
EU071391 Mucor flavus
CBS 201.65NT Mucor hiemalis






















Fig. 1  Neighbor-joining tree based on maximum composite likelihood corrected nucleotide distances among the ribosomal internal transcribed spacer 
(ITS) regions and 5.8S rRNA gene sequences of the strains of  Mucor and related taxa. Bootstrap support values above 70% are indicated at the nodes. 
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M. lusitanicus
CBS 135.65NT Mucor ramosissimus
CBS 108.19 Mucor circinelloides f. lusitanicus
AF113467 Mucor circinelloides f. lusitanicus
UTHSC 03-1823
CBS 108.17T Mucor circinelloides f. lusitanicus
UTHSC 03-1044
UTHSC 04-2492
CBS 236.35 Mucor fragilis
EU862173 Mucor fragilis
CBS 384.95 Mucor circinelloides f. circinelloides
FM246460 Mucor circinelloides f. circinelloides
CBS 195.68NT Mucor circinelloides f. circinelloides
UTHSC 04-1961 Mucor sp. 1
UTHSC 06-1667 Mucor sp. 1
UTHSC 02-1981 Mucor sp. 1
AY213712 Mucor racemosus




UTHSC 02-2090 Mucor sp. 2
AF113466 Mucor amphibiorum (type strain)
CBS 226.29T Mucor indicus
CBS 230.29 Mucor fuscus
CBS 132.22T Mucor fuscus
AF113470 Mucor mucedo
CBS 201.65NT Mucor hiemalis
CBS 103.93T Rhizomucor variabilis var. variabilis

















Fig. 2 Neighbor-joining tree based on maximum composite likelihood corrected nucleotide distances among the D1-D2 domains 28S rRNA gene 
sequences of the strains of  Mucor and related taxa. Bootstrap support values above 70% are indicated at the nodes. The bar indicates genetic distance. 
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DL: T-1721-2011 ramosa, 200 – 1000  μ m longa, 4 – 15  μ m lata; rami sporan-
giophoris 10 – 200  μ m longi, 5 – 12  μ m lati, eseptati vel cum 
septum 1-pluribus, hyalini vel brunnei, cum sporangio ter-
minatibus nonapophysati. Sporangia globosa vel subglo-
bosa, 15 – 60  μ m in diam, griseola vel griseola-brunnea, 
parietibus subpersistentibus, lente tabidis vel disruptis. 
Columellae globosae vel turbinatae, 10 – 50  μ m in diam, 
hyalinae vel brunneae; collaria distincta. Sporangiosporae 
globosae, subglobosae, ovoideae vel irregulares, 4 – 15  μ m 
in diam, griseo-brunneae, eminenter verrucosae. Zygospo-
rae ignotae.  Colonies velvety, 0.5 – 2 mm high, fi lling the Petri dish 
after 4 days of incubation at 25 ° C on MEA, at fi rst white, 
soon becoming mid gray (M. 1E1), reverse whitish. Rhiz-
oids abundant. Sporangiophores erect, mostly sympodi-
ally branched (5 – 15 times), 200 – 1000  μ m long, 4 – 15  μ m 
wide; branches 10 – 200  μ m long, 5 – 12  μ m wide, non-
septate or with one septum, colourless or brownish, simple, 
terminating in a non-apophysate sporangium. Sporangia 
globose or subglobose, 15 – 60  μ m diam, grey to greyish-
brown, wall slowly dissolving, sometimes broken. Colu-
mellae globose to conical, 10 – 50  μ m diam, hyaline to © 2011 ISHAM, Medical Mycology, 49, 62–72
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Table 2 Results of in vitro antifungal susceptibility testing.
 MIC (μg/ml)
AMB PSC  ITC
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DL: T-1721-2011 brown; collar  evident. Sporangiospores globose, subglo-
bose, ovoid or irregular, thick-walled, greyish-brown, 
4 – 15  μ m diam, coarsely verrucose. Chlamydospores 
terminal or intercalary, single or in short-chains (up to 4), 
hyaline to subhyaline, globose, ellipsoidal, barrel-shaped, 
cylindrical or irregular, 9 – 25   6 – 15  μ m, very thick-
walled, formed on hyphae, sporangiophores. Zygospores 
absent. 
 Colonies on PDA similar to those on MEA. On CZA 
the colonies were hyaline, and the reverse concolorous, 
with scarce aerial mycelium up to 2 mm high. The opti-
mum growth temperature was 25 ° C and the minimum 7 ° C. 
At 37 ° C growth occurred but sporulation was not observed. 
The fungus failed to grow at 42 ° C. 
 Holotype . CBS H-20399, from central venous line site, 
Connecticut, USA. Living cultures ex-type FMR 10020, 
UTHSC 02-1981 and CBS 126272 
 Etymology . The epithet  velutinosus refers to the velvety 
texture of the colonies. 
 Mucor ellipsoideus E.  Á lvarez, Cano, Stchigel, 
D. A. Sutton  & Guarro, sp. nov. (Fig. 4B; Fig. 6A – D) 
   Mucor sp. 2 sensu  Á lvarez  et al .  J Clin Microbiol 
2009;  47 : 1650 – 1656. 
 Ad 25 ° C in agaro cum decocto malturorum (MEA) 
coloniae velutinosae, 2 – 5 mm altae, Petri-patellas in die 
nono, primum albae, cito fl avidae (M. 4A3), in adversum 
fl avidum (M. 4A4). Sporangiophora erecta, simplicia et 
simpodialiter ramosis ad basim et bifurcata vel trifurcata 
ad apicem, 1000 – 3000  μ m longa, 4 – 10  μ m lata; rami spo-
rangiophoris 20 – 1000  μ m longi, 3 – 6  μ m lati, eseptati vel 
cum septum 1-pluribus, hyalini, cum sporangio terminati-
bus tenuiapophysati. Sporangia subglobosa, (11 – ) 16 – 48   
(12 – ) 18 – 50  μ m, pallide aurantiobrunnea, cum parietibus 
spinulosus, lente tabidis vel disruptis. Columellae globosae 
vel subglobosae, 10 – 45  μ m in diam, hyalinae; collaria © 2011 ISHAM, Medical Mycology, 49, 62–72indistincta. Sporangiosporae 4 – 8   2 – 3  μ m, hyalinae, 
levitunicatae. Zygosporae ignotae. 
 Colonies velvety, 2 – 5 mm high, fi lling the Petri dish 
after 9 days of incubation at 25 ° C on MEA, at fi rst white, 
soon becoming pale yellow (M. 4A3), reverse pale yellow 
(M. 4A4). Rhizoids very abundant, arising from various 
parts of the hyphae, simple or branched, non-septate, 
straight or curved, soon evanescent. Sporangiophores erect, 
simple and sympodially branched (5 – 10 times) at the base, 
and bi- to trifurcate at the apex, arising directly from super-
fi cial and aerial hyphae, 1000 – 3000  μ m long, 4 – 10  μ m 
wide; branches 20 – 1000  μ m long, 3 – 6  μ m wide, non-
septate or with one septum, colourless, simple. Sporangia 
subglobose, (11 – ) 16 – 48   (12 – ) 18 – 50  μ m , pale yellow-
ish-brown, with a spinulose wall, slowly dissolving, some-
times broken. Columellae globose to conical, 10– 45  μ m 
diam, hyaline, persistent, collapsing at the base; collar not 
evident. Sporangiospores narrowly ellipsoidal (sometimes 
fl attened at one side), 4 – 8   2 – 3  μ m, hyaline, smooth-
walled. Chlamydospores abundant, oidia-like, thick-walled, 
terminal or intercalary, single or in long chains, hyaline to 
subhyaline, globose, ellipsoidal, barrel-shaped, cylindrical 
or irregular, 4 – 30   7 – 20  μ m, very thick-walled, formed 
on hyphae, sporangiophores, sporangia, and rhizoids. 
Zygospores absent. 
 Colony features on PDA were similar to those seen on 
MEA. On CZA the colonies were hyaline with a concolor-
ous reverse. The optimum growth temperature was 25 ° C 
and the minimum 7 ° C. At 37 ° C growth and sporulation 
was observed. The fungus did not grow at 42 ° C. 
 Holotype . CBS H-20398, from peritoneal dialysis fl uid 
of a human patient with chronic renal failure, Florida, USA. 
Living cultures ex-type FMR 10021, UTHSC 02-2090 
and CBS 126271. 
 Etymology . The epithet  ellipsoideus refers to the shape 
of the sporangiospores. 
 Discussion 
 Variability of nucleotide sequences of the ITS region has 
been reported by several authors as a useful character to 
discriminate taxa included in the order Mucorales [19,20]. 
The ISHAM working group on fungal molecular identifi -
cation also proposed the use of ITS sequences as a reliable 
method for that purpose [21]. In a previous study, by using 
this marker, we were able to identify numerous species of 
Mucorales from clinical specimens in the US [9]. However, 
several  Mucor isolates could not be identifi ed in that study. 
Here they could be unambiguously identifi ed after mor-
phologically and genetically comparing these isolates with 
reference strains of related  Mucor species. The isolates 
UTHSC 04-1961, UTHSC 02-1981 and UTHSC 06-1667 
are described herein as the new species  M. velutinosus . 
 68 Álvarez et al.
Fig. 3  Mucor velutinosus UTHSC 02-1981. (A) Branching pattern of sporangiophores. (B) Columellae. (C) Sporangiospores. (D) Chlamydospores. 
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DL: T-1721-2011 This species showed a close molecular relationship with 
 M. circinelloides and  M. ramosissimus , but it can be 
differentiated from them by the production of larger and 
ornamented sporangiospores . Mucor velutinosus also 
shared some similarities with other species of  Mucor with sympodially branched sporangiophores and globose 
sporangiospores, such as  M. amphibiorum ,  M. fuscus and 
 M. plumbeus. However,  Mucor amphibiorum does not 
grow at 37 ° C, forms taller (up to 25 mm) colonies, broader 
(up to 20  μ m) sporangiophores and smooth-walled and © 2011 ISHAM, Medical Mycology, 49, 62–72
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Fig. 4 Mucor velutinosus UTHSC 02-1981. (A) Sporangium and 
sporangio spores (SEM). Mucor ellipsoideus UTHSC 02-2090. (B) 
Sporangium and sporangiospores (SEM). Scale is indicated by bars. 
Fig. 5 Morphology of colonies on PDA. (A) Mucor velutinosus UTHSC 
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DL: T-1721-2011 smaller (3.4 – 5.4  μ m diam) sporangiospores;  Mucor fuscus 
is the most similar species to  M. velutinosus since both 
produce ornamented sporangiospores, but this ornamenta-
tion consists of minute wall protrusions in  M. fuscus , being 
coarsely verrucose in  M. velutinosus . Moreover,  M. fuscus 
differs from  M. velutinosus by its lack of growth at 37 ° C, 
formation of pyriform and bigger (up to 80   52  μ m) 
columellae and sporangia (up to 140  μ m diam), and slightly 
smaller sporangiospores (up to 11  μ m diam).  Mucor 
plumbeus , also produces globose and verrucose sporangio-
spores, but its sporangiospores are less coarsely ornamented 
than those of  M. velutinosus , it produces columellae with 
one to several projections, and fails to grow at 37 ° C. 
 Isolate UTHSC 02-2090 is described herein as the new 
species  Mucor ellipsoideus . This species is genetically 
related to  M. amphibiorum and  M. indicus . However, 
M. ellipsoideus is easily differentiated from these, because © 2011 ISHAM, Medical Mycology, 49, 62–72 M. amphibiorum does not grow at 37 ° C, and produces 
smaller and spherical sporangiospores, and  M. indicus 
grows at 42 ° C, and produces smaller sporangia and smaller 
ellipsoidal sporangiospores [3,17]. 
 The other three clinical isolates, UTHSC 03-1823, 
UTHSC 03-1044 and UTHSC 04-2492, were identifi ed as 
 M. lusitanicus . Schipper [17] had considered  M. circinel-
loides f. lusitanicus as different from  M. circinelloides f. 
circinelloides based on the shape and size of the sporan-
giospores. We examined these fungi morphologically and 
agree with Schipper that they are phenotypically different. 
These differences were confi rmed in our phylogentic study; 
however, we conclude as previously reported, that these 
two fungi must be considered as two different species, i.e., 
 M. lusitanicus and  M. circinelloides [22,23], instead of two 
 formae of the same species. Consequently, the two clinical 
isolates were identifi ed as  M. lusitanicus . 
 Isolate UTHSC 04-2492 grouped, in our phylogenetic 
analyses, with a strain of  M. fragilis (CBS 236.35), and 
two sequences deposited in the GenBank as  M. fragilis 
(EU862184 and EU484238). Unfortunately, the type of 
this species does not exist and strain CBS 236.35, identi-
fi ed by Zycha in 1935 [24], is the only reference strain 
available of that species. We agree with Schipper [15] that 
this strain differs from the original description of the spe-
cies [25] in important characters, e.g., it does not produce 
zygospores, and its sporangiospores are larger (4 – 10   
3 – 7  μ m vs. 4.2   2.1  μ m in  M. fragilis original descrip-
tion) and they are not bluish. By contrast, this isolate is 
morphologically similar to the strains of  M. lusitanicus 
 70 Álvarez et al.
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DL: T-1721-2011 included in our study, showing a percentage of similarity 
with the type strain of this species (CBS 108.17) of 98% 
(ITS region) and 99.6% (D1-D2 domains). 
 Taxonomy of the genus  Rhizomucor , a genus morpho-
logically close to  Mucor , is unresolved. Previously, we 
demonstrated that  Rhizomucor variabilis var.  regularior 
and  R. variabilis var.  variabilis were two different species 
genetically related to  Mucor spp. and clearly separate from 
 Rhizomucor pusillus , the type species of the genus [9]. 
 Rhizomucor variabilis var.  regularior is morphologically 
and genetically indistinguishable from  M. circinelloides 
[9] and R. variabilis var.  variabilis, in the present study, is 
genetically related to  Mucor hiemalis and  M. mucedo . Pro-
duction of rhizoids and thermophilic capabilities have been 
traditionally considered as the main features that differen-
tiate  Rhizomucor from  Mucor ; however, these characters 
should be considered as homoplasious, since several spe-
cies of  Mucor , such as  M. circinelloides and  M. velutinosus produce rhizoids too, and also some species of  Mucor , such 
as  M. indicus, are thermotolerant. A detailed examination 
of the most important morphological characteristics of 
 R. variabilis var.  variabilis and  R. variabilis var.  regularior 
revealed that there are not enough features to separate 
them from  Mucor and hence we propose the following 
taxonomic changes: 
 Mucor circinelloides Tieghem  – Annls Sci. nat. 1: 94. 
1875 
 Mucor ambiguus Vuill.  – Bull. Soc. Sci. Nancy 8: 92. 1886 
 Mucor alternans Tieghem in Gayon  & Dubourg – Annls 
Inst. Pasteur, Paris 1: 532. 1887 
 Mucor javanicus Wehmer  – Zentbl. Bakt. ParasitKde, Abt. 
2, 6: 619. 1900 
 Mucor dubius Wehmer  – Zentbl. Bakt. ParasitKde, Abt. 
2 , 7: 318. 1901 ( nomen provisorium ). © 2011 ISHAM, Medical Mycology, 49, 62–72
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DL: T-1721-2011  Mucor prainii Chodat  & Nechitch in Nechitch  – Sur les 
ferments de deux levains de I ’ Inde. Le Mucor Prainii et le 
Dematium chodati, Geneve, p. 38. 1904 
 Mucor griseo-roseus Linnemann  – Beitrag zu einer Flora 
der Mucorineae Marburgs, p. 189. 1936 
 Mucor ramifi cus B. S. Mehrotra  & Nand  – Sydowia 20: 
69. 1966 
 Mucor mandshuricus Saito  – Rep. cent. Lab. S. Mandsch. 
Railw. Co. 1: 16. 1914    Mucor  circinelloides Tieghem 
var.  mandshuricus (Saito) Milko  – Atlas mucoral ’ nykh 
gribov, p. 67. 1971 
 Circinomucor circinelloides (Tiegh.) Arx  – Sydowia  35 : 
18. 1982 
 Rhizomucor variabilis var . regularior R. Y. Zheng  & G. Q. 
Chen - Mycosystema  6 : 2. 1993 
 M ucor lusitanicus Bruderl.  – Bull. Soc. Bot. Gen è ve  8 : 
276. 1916 
 Mucor griseo-lilacinus Povah  – Bull. Torrey bot. Club  44 : 
301. 1917. 
 Mucor jauchae Lendner  – Bull. Soc. bot. Geneve  10 : 374. 
1918 
 Mucor zeicolus Graff  – CBS List of Cultures, p. 71. 1939 
( nomen nudum ) © 2011 ISHAM, Medical Mycology, 49, 62–72ucor racemosus Fresen var.  lusitanicus (Bruderlein) 
aumov  – Cl é s des Mucorin é es (Mucorales), p. 47. 1939 
ucor circinelloides Tiegh. f.  lusitanicus (Bruderl.) Schip-
er  – Stud. Mycol.  12 : 9. 1976 
 Mucor irregularis Stchigel, Cano, Guarro  &  Á lvarez, 
om. nov. 
   Rhizomucor variabilis var.  variabilis R. Y. Zheng  & 
. Q. Chen, Mycosystema  4 : 47. 1991 
 Non  M. variabilis A.K. Sarbhoy, Trans. Br. mycol. Soc. 
8 : 559. 1965.  Key to distinguish the most relevant clinical species of Mucor 
 (1) Sporangiophores unbranched or weakly branched ..........................................................................................................2 
 Sporangiophores repeatedly branched ............................................................................................................................. 3 
 (2) Sporangiospores spherical, 3.4 – 5.4  μ m in diam....................................................................................  M. amphibiorum 
 Sporangiospores ellipsoidal, 5.7 – 8.7   2.7 – 5.4  μ m .....................................................................................  M. hiemalis 
 (3) Growth at 40 ° C ................................................................................................................................................  M. indicus 
 No growth at 40 ° C ...........................................................................................................................................................4 
 (4) Sporangiospores globose or nearly so ............................................................................................................................. 5 
 Sporangiospores otherwise ............................................................................................................................................... 8 
 (5) Sporangiospores verrucose ............................................................................................................................................... 6 
 Sporangiospores smooth-walled ....................................................................................................................................... 7 
 (6) Growing at 37 ° C; sporangiospores coarsely ornamented ..........................................................................  M. velutinosus 
 No growth at 37 ° C; sporangiospores fi nely ornamented .............................................................................. M. plumbeus 
 (7)  Growing at 35 ° C; sporangiophores with several swellings; sporangia on short lateral branches;  
sporangiospores 5.0 – 8.0   4.5 – 6.0  μ m .................................................................................................  M. ramosissimus 
 No growth at 35 ° C; sporangiophores lack swellings; sporangia on long lateral branches;  
sporangiospores 5.5 – 10.0   4.0 – 7.0  μ m ....................................................................................................  M. racemosus 
 (8) Sporangiospores ellipsoidal, 4.4 – 6.8   3.7 – 4.7  μ m .............................................................................  M. circinelloides 
 Sporangiospores very variable in shape ...........................................................................................................................9 
 (9) Columellae irregular in shape; sporangiospores 2.5 – 16.5   2.0 – 7.0  μ m .................................................  M. irregularis 
 Columellae globose; sporangiospores 5.5 – 17.6   3.4 – 12.8  μ m ............................................................... M. lusitanicus  In the D1 – D2 rDNA phylogeny,  Chaetocladium brefel-
dii ,  Kirkomyces cordense , and  Parasitella parasitica were 
genetically related to some species of  Mucor . Such a rela-
tionship was also reported by O ’ Donnell  et al . [2] based 
on phylogenetic analyses of the 18S rDNA and translation 
elongation factor genes. On the basis of the clear polyphyly 
of  Mucor , further molecular phylogenetic analyses are 
needed to delimit natural taxa and relationships. The genus 
 Parasitella was erected by Bainier [25] (1903) to accom-
modate  Mucor  parasiticus , which is morphologically 
related to other species of the genus  Mucor , but differs 
from them by its ability to parasite other Mucorales and by 
the presence of digitiform projections on the suspensors of 
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DL: T-1721-2011 the zygospores [26]. Later, other authors [5,24,27] also dif-
ferentiated  Parasitella from  Mucor by the production of 
nodose vegetative structures derived from the fusion of the 
parasite and the host hyphae. However, these morphologic 
and ecologic differences do not appear to be suffi cient to 
consider  Parasitella and  Mucor as separated genera. The 
placement of  Chaetocladium and  Kirkomyces intermixed 
with different  Mucor species in the phylogenetic trees 
reported by O ’ Donnell  et al . [2] demonstrated the poly-
phyly of  Mucor. 
 Antifungal susceptibility results showed that amphoteri-
cin B is the most active antifungal agent against the new 
species (Table 2), a fact reported by many other authors for 
other species of  Mucor of clinical importance [28]. Posa-
conazole and itraconazole showed limited activity. 
 A dichotomous key to distinguish the most relevant 
clinical species of  Mucor is provided ( M. ellipsoideus is 
not included since it was only isolated once from peritoneal 
dialysis fl uid and its true clinical role is problematic). 
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4.3 Molecular phylogenetic diversity of the emerging mucoralean 
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Background: Apophysomyces is a monotypic genus belonging to the order Mucorales. The species
Apophysomyces elegans has been reported to cause severe infections in immunocompromised and
immunocompetent people. In a previous study of Álvarez et al.3 [J Clin Microbiol 2009;47:1650–6], we
demonstrated a high variability among the 5.8S rRNA gene sequences of clinical strains of A. elegans.
Material and methods: We performed a polyphasic study based on the analysis of the sequences of the
histone 3 gene, the internal transcribed spacer region of the rDNA gene, and domains D1 and D2 of the 28S
rRNA gene, as well as by evaluation of some relevant morphological and physiological characteristics of a
set of clinical and environmental strains of A. elegans.
Results and conclusions: We have demonstrated that A. elegans is a complex of species. We propose as new
species Apophysomyces ossiformis, characterised by bone-shaped sporangiospores, Apophysomyces
trapeziformis, with trapezoid-shaped sporangiospores, and Apophysomyces variabilis, with variable-shaped
sporangiospores. These species failed to assimilate esculin, whereas A. elegans was able to assimilate that
glycoside. Amphotericin B and posaconazole are the most active in vitro drugs against Apophysomyces.
& 2009 Revista Iberoamericana de Micologı́a. Published by Elsevier España, S.L. All rights reserved.Diversidad filogenética del hongo mucoral emergente Apophysomyces:







ZigomicetosR E S U M E N
Antecedentes: Apophysomyces es un género monoespécifico perteneciente al orden Mucorales. La especie
Apophysomyces elegans, ha sido reportada como causante de infecciones severas en pacientes
inmunocomprometidos e inmunocompetentes. En un estudio previo (Álvarez et al., J Clin Microbiol.
2009;47:1650–6 ), demostramos la elevada variabilidad dentro de las secuencias del gen 5.8S del ARNr en
un grupo de cepas clı́nicas de A. elegans.
Material y métodos: Hemos realizado un estudio polifásico basado en el análisis de las secuencias del gen
de la histona 3, la región de los espaciadores internos del ADNr y los dominios D1 y D2 del gen 28S del
ARNr, ası́ como la evaluación de caracteres morfológicos y fisiológicos relevantes de un grupo de cepas
clı́nicas y ambientales de A. elegans.
Resultados y conclusiones: Hemos demostrado que A. elegans es un complejo de especies. Proponemos
como nuevas especies para la ciencia Apophysomyces ossiformis, caracterizada por sus esporangiosporas con
forma de hueso; Apophysomyces trapeziformis, con esporangiosporas trapezoidales; y Apophysomyces
variabilis, con esporangiosporas de formas variables. Las nuevas especies no asimilan la esculina, en tanto
que A. elegans fue capaz de asimilar dicho glicósido. La anfotericina B y el posaconazol fueron los
antifúngicos más activos frente a Apophysomyces.
& 2009 Revista Iberoamericana de Micologı́a. Publicado por Elsevier España, S.L. Todos los derechos
reservados.The genus Apophysomyces, belonging to the subphylum Mucor-
omycotina (oldest phylum Zygomycota),11 was erected by Misra
et al.18 in 1979 to accommodate the only species of the genus,mericana de Micologı́a. PublishedApophysomyces elegans, which was isolated from soil samples in
northern India. This fungus was characterized by pyriform
sporangia, conspicuous funnel- and/or bell-shaped apophyses, and
subhyaline, thin-, and smooth-walled sporangiospores that are
mostly oblong with rounded ends. It is a thermotolerant fungus that
grows rapidly between 26 and 42 1C.6,18 A. elegans is not only
isolated from soil, decaying vegetation, and as an environmentalby Elsevier España, S.L. All rights reserved.
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infections.8 Unlike other members of Mucorales, this fungus
primarily infects immunocompetent hosts.17 The infection typically
follows traumatic implantation of the agent, but may also result
from inhalation of spores into the sinus.5,6,12,15,17,21 This disease is
more common in tropical and subtropical climates. Cases have been
reported in Australia,6,20 India,5,13,14,26 the United States,3,15 Sri
Lanka,4 Thailand,24 and in Central and South America.21,22
The genetic population structure of A. elegans remains largely
unknown and may be due in part to the lack of preservation of
strains for study. In a recent survey on the spectrum of species
of Mucorales from clinical sources in the United States, we
demonstrated a high intraspecific 5.8S rRNA gene sequence
diversity in A. elegans.3 Additionally, in a typing study of
A. elegans using microsatellites markers, it was demonstrated that,
in a set of clinical strains, mainly from India, different banding
patterns exist.5 These data suggest that more than one phylogenetic
species may be present within the morphospecies A. elegans.
To determine possible cryptic species in A. elegans, we
performed a polyphasic study on a diverse panel of strains, based
on a multilocus sequence analysis of three loci (the histone 3 gene
(H3), internal transcribed spacer region of the rDNA (ITS), and
domains D1 and D2 of the 28S rRNA gene) and the evaluation of
different morphological and physiological characters.Materials and methods
Fungal strains
A total of 16 strains from different origins were included in the
study (Table 1). The fungi were cultured on potato dextrose agar
(PDA, Pronadisa, Madrid, Spain) and incubated at 3571 1C for 2–5
days.DNA extraction, amplification, and sequencing
DNA was extracted and purified directly from fungal colonies
following a slightly modified Fast DNA kit protocol (Bio101, Vista,Table 1
Origin of Apophysomyces strains included in the study
Isolate Source ITS1
CBSa 476.78 Soil, Deoria, India FN5
CBS 477.78 Soil, Gorakhpur, India FN5
CBS 658.93 Osteomyelitis, Netherlands Antilles FN5
GMCHb 480/07 Cutaneous infection, India FN5
GMCH 211/09 Cutaneous infection, India FN5
IMIc 338332 Ankle aspirate, Australia FN5
IMI 338333 Daly river, Australia FN5
UTHSCd 03-3644 Dolphin, Florida, USA FN5
UTHSC 04-838 Cellulitis wound leg, Minnesota, USA FN5
UTHSC 04-891 Sinus, Minnesota, USA FN5
UTHSC 06-2356 Dolphin, Texas, USA FN5
UTHSC 06-4222 Dolphin, Bahamas FN5
UTHSC 07-204 Facial cellulitis, Arizona, USA FN5
UTHSC 08-1425 Abdominal tissue, Phoenix, USA FN5
UTHSC 08-2146 Skin biopsy, Colorado, USA FN5
UTHSC R-3841 Necrotic face tissue, Georgia, USA FN5
a CBS, Centraalbureau voor Schimmelcultures, Utrecht, Netherlands.
b GMCH, Government Medical College and Hospital, Chandigarh, India.
c IMI, International Mycological Institute, CABI-Bioscience, Egham, UK.
d UTHSC, Fungus Testing Laboratory, University of Texas Health Science Center, SaCA, USA), consisting of a homogenization step repeated three times
with a FastPrep FP120 instrument (Thermo Savant, Holbrook, NY,
USA). DNA was quantified by the GeneQuant pro (Amersham
Pharmacia Biotech, Cambridge, England). The internal transcribed
spacer (ITS) region of the nuclear rDNA was amplified with the
primer pair ITS5 and ITS4, the D1–D2 domains of the 28S rRNA gene
were amplified with the primer pair NL1–NL4, and histone 3 (H3)
gene was amplified with the primer pair H3-1a–H3-1b.10
The PCR mix (25ml) included 10 mM Tris–HCl (pH 8.3), 50 mM
KCl, and 2.5 mM MgCl2 (10 Perkin-Elmer buffer II plus MgCl2
solution Roche Molecular Systems, Branchburg, NJ, USA), 100mM
of each dNTP (Promega, Madison, WI, USA), 1mM of each primer,
and 1.5 U of AmpliTaq DNA polymerase (Roche). The amplification
program for the three DNA fragments included an initial
denaturation at 94 1C for 5 min, followed by 35 cycles of
denaturation at 95 1C for 30 s, annealing for 1 min at 54 1C, and
extension for 1 min at 72 1C. The products were purified with an
Illustra GFXTM PCR DNA and Gel Band Purification Kit (General
Electric Healthcare, Buckinghamshire, UK) and stored at 20 1C
until they were used in sequencing. PCR products were sequenced
using the same primers employed for amplification and following
the Taq DyeDeoxy Terminator Cycle Sequencing Kit protocol
(Applied Biosystems, Gouda, Netherlands). Reactions were run
on a 310 DNA sequencer (Applied Biosystems). Consensus
sequences were obtained using the Autoassembler program
(Perkin-Elmer-Applied Biosystems) and Seqman software (Laser-
gene, Madison, WI).
Phylogenetic analyses
The sequences were aligned using Clustal X (version 1.8)
computer program, followed by manual adjustments with a text
editor. Most-parsimonious tree (MPT) analyses were performed
using PAUP* version 4.0b10. One hundred heuristic searches were
conducted with random sequence addition and tree bisection–
reconnection branch-swapping algorithms, collapsing zero-length
branches, and saving all minimal-length trees (MulTrees). Sakse-
naea vasiformis (FMR 10131) was chosen as the outgroup. Support
for internal branches was assessed using a heuristic parsimony
search of 1000 bootstrapped data sets. The combined data set of
the ITS, D1–D2, and H3 was tested for incongruence with theGenBank accession no.
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Kishino–Hasegawa test was performed to determine whether
trees differed significantly. Gaps were treated as missing data.
Morphological studies
The strains were subcultured on PDA, Czapek agar (CZA; Difco,
Becton Dickinson, France), malt extract agar (MEA; 10 g of malt
extract, 20 g of agar, and 1000 ml of distilled water), and starch
agar (SA; 5 g of soluble starch, 15 g of agar, and 1000 ml of distilled
water), and incubated at 37 and 42 1C. The microscopic features
were determined on the sixth day in wet mounts on water and on
lactic acid, which were examined under a light microscope. The
strains were identified using schemes based on morphological
characters.8,18
Physiological studies
Growth rates at 4, 15, 24, 30, 35, 37, 42, and 50 1C were
determined on PDA, MEA, CZA, and SA for each of the strains
included in the study. The Petri dishes were inoculated in the
center, incubated in darkness, and the colony diameters (in
millimeters) were measured daily.
Carbon source assimilation profiles were determined with the
commercial kit API 50 CH (bioMérieux, Marcy, l’Etoile, France),
following protocols described previously but with minor modi-
fications.23 To obtain sufficient sporulation, all strains were cultured
for 6 days on CZA at 42 1C. A final concentration of 5105 CFU/ml
was prepared in 20 ml of yeast nitrogen base (7.7 g/l; Difco),
containing 0.5 g/l L-chloramphenicol (Sigma-Aldrich) and 0.1%
Bacto agar (Difco), and each well of the strips was inoculated with
300ml of medium. The viability of the conidia was verified by
plating 100ml of serial dilutions of each inoculum onto PDA and
incubating at 42 1C for 6 days. The inoculated API 50 CH strips were
incubated for 48–72 h at 37 1C in darkness. After incubation, the
strips were read visually and growth or lack of growth was noted.
Weak growth was considered as a positive result. For nitrogen
source assimilations, we used the same inoculum described above,
but the yeast nitrogen base broth was replaced by carbon nitrogen
base broth (Difco), and testing was performed in sterile, disposable,
multiwell microplates. The medium with the nitrogen sources was
dispensed into the wells in 150ml volumes with a multichannel
pipette and each well was inoculated with 50ml of the conidial
suspension. The microplates were incubated at 37 1C in darkness for
48 and 72 h. We also determined growth of the strains on NaCl (2%,
5%, 7%, 10%), MgCl2 2%, and cycloheximide 0.1%.
9,27 All tests were
performed in duplicate.
The production of urease was determined after incubation on
Christensen’s urea agar slants at 37 1C for 8 days.16
Mating tests
Sixteen Apophysomyces strains were grown on CZA plates at
37 1C in the dark, and then paired in all combinations, including
self-crosses, on CZA. Each strain was streaked onto one half of a
CZA plate opposite to the streak of another strain, allowing for a
central zone of contact as the strains grew. Plates were incubated
at 37 1C and examined macroscopically each week for up to 6
months for the presence of zygospores. All tests were performed
in duplicate.
Antifungal susceptibility testing
The in vitro activity of seven antifungal agents against the 16
strains of Apophysomyces was evaluated according to Clinical andLaboratory Standards Institute guidelines (M38-A2).19 The drugs
tested were amphotericin B (USP, Rockville, MD, USA), anidula-
fungin (Pfizer Inc., New York, NY, USA), caspofungin (Merck & Co.,
Inc., Rahway, NJ, USA), itraconazole (Jansen Pharmaceutica,
Beerse, Belgium), posaconazole (Schering-Plough Ltd., Hertford-
shire UK), ravuconazole (Bristol-Myers Squibb Company, New
Brunswick, NJ, USA), and voriconazole (Pfizer Inc., New York,
NY, USA).Nucleotide sequence accession numbers
All the sequences obtained in this study were deposited in
GenBank database and assigned the accession numbers listed in
Table 1.Results
Phylogeny
With the primers used, we were able to amplify and sequence
684–820, 582–683, and 345–382 bp of the ITS, D1–D2, and H3
loci, respectively. Of the 1630 nucleotides sequenced, 48 charac-
ters were parsimony informative in the different strains, the
lowest number was eight for the H3 gene, and the highest was 27
for the ITS region. Sequences of the three region genes were
analyzed phylogenetically as separate (data not shown) and
combined datasets. The partition homogeneity test demonstrated
that the three loci sequence data sets were congruent (P=0.05)
and could therefore be combined. A total of 36 MPT was produced
from a heuristic search, using the combined dataset from the
three loci (Fig. 1). The trees had a consistency index of 0.969, a
retention index of 0.956, and a homoplasy index of 0.031.
Clustering was similar to that observed in the particular trees of
the different genes analyzed. Most nodes in the combined analysis
showed increased clade support as measured by bootstrapping
(six nodes with Z70%). Analyses of the combined partitions
support the recognition of four well supported clades (Fig. 1), each
of which could be considered separate phylogenetic species. Clade
1 (bootstrap support (bs) 73%) was composed of two strains from
India, two from Australia, and one strain each from the United
States, Netherlands Antilles, and Bahamas. Within clade 2
(bs 100%) were included the type strain of A. elegans and one
strain from Indian soil. In clade 3 five strains (bs 96%) were
located, four of them of clinical origin from the United States, and
one from a dolphin. Finally, clade 4 (bs 98%) consisted of two
clinical strains, both from the United States.Physiology
Carbon assimilation profiles of the different strains on API
50CH strips are shown in Table 2. Assimilation patterns of all the
strains were positive for 20 tests. Twenty-seven carbon sources
were not assimilated by any strain. The profiles of assimilation of
two carbon sources, esculin and D-lyxose, were species- and
strain-dependent, respectively. Esculin was weakly assimilated
only by the strains nested in clade 2. The assimilation of D-lyxose
was highly variable among the strains of the different clades. By
contrast, the variability in the assimilations of nitrogen sources,
and tolerance to NaCl, MgCl2, and cycloheximide was nule among
the species (Table 3). All the strains were positive for 11 nitrogen
sources. Nitrite was not assimilated by any of the strains. All
strains were able to grow at 2% NaCl and at 2% MgCl2, but failed to




Tree length = 226
Consistency index = 0.9690
Homoplasy index = 0.0310
































Saksenaea vasiformis (FMR 10131)
Fig. 1. One of the 36 most parsimonious trees obtained from heuristic searches based on analysis produced from the combined data set. Sequence of Saksenaea vasiformis
was chosen as outgroup. Bootstrap support values above 70% are indicated at the nodes. T: Type strain.
E. Alvarez et al / Rev Iberoam Micol. 2010;27(2):80–89 83
UNIVERSITAT ROVIRA I VIRGILI 
TAXONOMY AND PHYLOGENY OF CLINICALLY IMPORTANT MUCO ALEAN FUNG  
Eduardo Álvarez Duarte 
DL: T-1721-2011 Morphology
In general, all the strains examined displayed the typical
features of the genus Apophysomyces described by Misra et al.18
However, a more detailed microscopic study of these fungi
showed important and consistent differences, mainly in the
morphology of sporangiophores and sporangiospores, which
correlated with the different phylogenetic species. The strains
included in clade 1 showed some morphological diversity. The
sporangiospores ranged from broadly clavate to ellipsoidal, were
flattened on one side, and measured 5–143–6mm. The strains
included in clade 2, which comprises the type strain of A. elegans,
showed ovoid, subspherical, broadly ellipsoidal to barrel shaped
sporangiospores, although more irregularly shaped spores were
also present, measured 6–125–8mm, and were the largest for
the different species in the complex. The sporangiospores of the
strains included in clade 3 were trapezoidal and smaller
(5–8.53–5mm) while those of strains in clade 4 were thick-
walled and clearly biconcave (bone-shaped) in side view,
measuring 6–83–5.5mm. In addition to differences in spore
morphology, the strains in clade 2 also showed two types of
sporangiophores: (i) large (up to 540mm), bearing vase- or bell-
shaped apophyses and (ii) shorter (up to 400mm), bearing funnel-
shaped apophyses. The sporangiophores in strains of clades 1, 3,
and 4 are similar to the short ones of clade 2.Mating test
Zygospore formation was not observed after 6 months of
incubation in all the mating tests assayed.
Based on the described morphological and physiological
differences, which correlated with the molecular data, we
concluded that clades 1, 3, and 4 represent three species of
Apophysomyces, different from A. elegans (clade 2), which are
proposed here as new species.
Apophysomyces variabilis Alvarez, Stchigel, Cano, D.A. Sutton et
Guarro, sp. nov. (Figs. 2A, B; 3H, I).Coloniae in CZA ad 37 1C rapide crescentes, albae, sed
sparsis, inmersis pro parte maxima compositae. Sporangio-
phora erecta, plerumque simplicia, 100–400mm longa,
2–3.5mm lata, brunnea, cum sporangio apohysati. Apophyses
plerumque infundibuliformes, 15–2015–20mm2. Sporan-
giosporae variabiles in forma et magnitudine, trapezoides,
ellipsoideae, subtriangulares vel claviformis, 5–14 3–6mm2.
Holotypus, CBS H-658.93, ex osteomielitis (cultura viva FMR












Carbon assimilation profiles for Apophysomyces species obtained with API 50 CH strips
Species

































GLY (glycerol) + + + + + + + + + + + + + + + +
ERY (erythritol)                
DARA (D-arabinose)                
LARA (L-arabinose) + + + + + + + + + + + + + + + +
RIB (D-ribose) + + + + + + + + + + + + + + + +
DXYL (D-xylose) + + + + + + + + + + + + + + + +
LXYL (L-xylose)                
ADO (D-adonitol) + + + + + + + + + + + + + + + +
MDX (methyl-ß-D-
xylopyranoside)
               
GAL (D-galactose)                
GLU (D-glucose) + + + + + + + + + + + + + + + +
FRU (D-fructose) + + + + + + + + + + + + + + + +
MNE (D-mannose) + + + + + + + + + + + + + + + +
SBE (L-sorbose)                
RHA (L-rhamnose)                
DUL (dulcitol)                
INO (inositol)                
MAN (D-mannitol) + + + + + + + + + + + + + + + +
SOR (D-sorbitol) + + + + + + + + + + + + + + + +
MDM (methyl-D-
mannopyranoside)
               
MDG (methyl-D-
glucopyranoside)
               
NAG (N-acetyl-
glucosamine)
+ + + + + + + + + + + + + + + +
AMY (amygdalin)                
ARB (arbutin)                
ESC (esculin)        + +       
SAL (salicin)                
CEL (D-cellobiose) + + + + + + + + + + + + + + + +
MAL (D-maltose) + + + + + + + + + + + + + + + +
LAC (D-lactose)                
MEL (D-melibiose)                
SAC (D-saccharose)                
TRE (D-trehalose) + + + + +  + + + + + + + + + +
INU (inulin)                
MLZ (D-melezitose) + + + + +  + + + + + + + + + +
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AMD (amidon) + + + + + +  + + + + + + + + +
GLYG (glycogen) + + + + + + + + + + + + + + + +
XLT (xylitol) + + + + + + + + + + + + + + + +
GEN (gentiobiose)                
TUR (D-turanose)                
LYX (D-lyxose)     + +     +    + +
TAG (D-tagatose)                
DFUC (D-fucose)                
LFUC (L-fucose)                
DARL (D-arabitol) + + + + + + + + + + + + + + + +
LARL (L-arabitol) + + + + + + + + + + + + + + + +
GNT (potassium gluconate)                
2KG (potassium 2-keto-
gluconate)
               
5KG (potassium 5-keto-
gluconate)
               
Table 3
Nitrogen assimilation and tolerance to chemical compounds for the Apophysomyces species included in this study
Species







































Cadaverine + + + + + + + + + + + + + + + +
Creatine + + + + + + + + + + + + + + + +
Creatinine + + + + + + + + + + + + + + + +
L-lysine + + + + + + + + + + + + + + + +
Nitrate + + + + + + + + + + + + + + + +
Nitrite                
L-tryptophan + + + + + + + + + + + + + + + +
L-proline + + + + + + + + + + + + + + + +
L-leucine + + + + + + + + + + + + + + + +
L-ornithine + + + + + + + + + + + + + + + +
L-cysteine + + + + + + + + + + + + + + + +
Arginine + + + + + + + + + + + + + + + +
2% NaCl + + + + + + + + + + + + + + + +
5% NaCl                
7% NaCl                
10% NaCl                
2% MgCl2 + + + + + + + + + + + + + + + +
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Fig. 2. Morphology of the apophyses and sporangiospores of Apophysomyces: (A, B) A. variabilis CBS 658.93 (A, apophyses funnel-shaped; B, sporangiospores). (C, D)
A. ossiformis UTHSC 04-838 (C, apophyses funnel-shaped; D, bone-like shaped sporangiospores). (E) A. trapeziformis UTHSC 08-1425 (E, trapezoid-shaped sporangiospores).
(F, G) A. elegans CBS 476.78 (F, apophyses bell- and funnel-shaped; (G) subspherical to broadly ellipsoidal sporangiospores). All bars=10mm.
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DL: T-1721-2011 Colonies attaining a diameter of 90 mm after 4 days of
incubation at 37 1C on CZA, whitish, with scarce aerial mycelium;
hyphae branched, hyaline, smooth-walled, 3–5.5mm in diameter;
reverse concolorous. Sporangiophores erect, generally arising singly,
at first hyaline, soon becoming light greyish brown, generally
straight, slightly tapered towards the apex, unbranched, 100–
400mm long, 2–3.5mm wide, and smooth-walled. Sporangia
apophysate, terminal, pyriform, multispored, white at first,
becoming light greyish brown when mature, and 15–50mm
in diameter. Apophyses short, funnel-shaped, and 15–2015–20mm. Sporangiospores variable in shape, trapezoid, ellipsoid,
subtriangular or claviform, hyaline to light brown in mass, smooth-
and thin-walled, and 5–143–6mm. Not able to assimilate esculin.
Colonies on SA, PDA, and MEA showed similar features
than on CZA, but they were more floccose, white, and with less
sporulation. The optimum growth temperature was 35–42 1C and
the minimum temperature of growth was 15 1C. The fungus did
not grow at 50 1C.
Apophysomyces ossiformis Alvarez, Stchigel, Cano, D.A. Sutton et
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DL: T-1721-2011 Coloniae in CZA ad 37 1C rapide crescentes, albae, sed
sparsis, inmersis pro parte maxima compositae. Sporangio-
phora erecta, plerumque simplicia, 100–400mm longa,
2–3.5mm lata, brunnea, cum sporangio apohysati. Apophyses
plerumque infundibuliformes, 15–2015–20mm. Sporangios-
porae ossiformis, 6–83–5.5mm. Holotypus, CBS H-20328, ex
cellulitis cruris vulnus hominis (cultura viva FMR 9913,
UTHSC 04-838).. 3. (A)–(C) Apophysomyces elegans (A, vessel-shaped sporangiophore; B, funnel
sporangiophore; E, sporangiospore, frontal and side views). (F, G) Apophysomyces tr
sporangiophore; I, sporangiospores). Bars: 10mm.Etymology: the epithet refers to the bone-like shape of the
sporangiospores.
Colonies attaining a diameter of 90 mm after 4 days of
incubation at 37 1C on CZA, whitish, with scarce aerial mycelium,
branched, hyaline, smooth-walled, and 3–5.5mm in diameter;
reverse concolorous. Sporangiophores erect, generally arising
singly, at first hyaline soon becoming light greyish brown,
generally straight, slightly tapered towards the apex, unbranched,
100–400mm long, 2–3.5mm wide, and smooth-walled. Sporangia
apophysate, terminal, pyriform, multispored, white at first,-shaped sporangiophore; C, sporangiospores). (D, E) Apophysomyces ossiformis
apeziformis (F, sporangiophore; G, sporangiospore). (H, I) Apophysomyces variabilis
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Table 4
In vitro antifungal susceptibility data for Apophysomyces species
Species (] of strains tested) Antifungal agent MIC or MEC (lg/mL) 24 h
GM Range
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DL: T-1721-2011 becoming light greyish brown when mature, 15–50mm in
diameter. Apophyses short, funnel-shaped, 15–2015–20mm.
Sporangiospores mostly bone-like shaped, hyaline to light brown
in mass, smooth- and thick-walled, and 6–83–5.5mm. Not able
to assimilate esculin.
Colonies on SA, PDA, and MEA showed similar features than on
CZA, but they were more floccose, white, and with less sporula-
tion. The optimum growth temperature was 35–42 1C and the
minimum 15 1C. The fungus did not grow at 50 1C.
Apophysomyces trapeziformis Alvarez, Cano, Stchigel, D.A.




















Caspofungin 32.0 o16Coloniae in CZA ad 37 1C rapide crescentes, albae, sed
sparsis, inmersis pro parte maxima compositae. Sporangio-
phora erecta, plerumque simplicia, usque ad 400mm longa,
2–3.5mm lata, brunnei, cum sporangio apohysati. Apophyses
plerumque infundibuliformes, 15–2015–20mm. Sporangios-
porae trapezoids vel ellipsoideae, 5–8.5 3–5mm.
Holotypus, CBS H-20329, ex abscessus abdominis huma-
nus (cultura viva FMR 10456, UTHSC 08-1425).
Etymology: the epithet refers to the trapezoid shape of the
sporangiospores in side view.
Colonies attaining a diameter of 90 mm after 4 days of
incubation at 37 1C on CZA, whitish, with scarce aerial mycelium,
branched, hyaline, smooth-walled, 3–5.5mm in diameter; reverse
concolorous. Sporangiophores erect, generally arising singly, at
first hyaline soon becoming light greyish brown, generally
straight, slightly tapered towards the apex, unbranched, up to
400mm long, 2–3.5mm wide, and smooth-walled. Sporangia
apophysate, terminal, pyriform, multispored, white at first,
becoming light greyish brown when mature, and 15–50mm in
diameter. Apophyses short, funnel-shaped, and 15–20
15–20mm. Sporangiospores mostly trapezoid-shaped in side
view, more or less cylindrical in front view, flattened at one side
and broadly convex on opposite side, hyaline to light brown in
mass, smooth- and thin-walled, and 5–8.53–5mm. Not able to
assimilate esculin.
Colonies on SA, PDA, and MEA showed similar features than
on CZA, but they were more floccose, white, and with less
sporulation. The optimum growth temperature was 35–42 1C and
the minimum 15 1C. The fungus did not grow at 50 1C.
Based on our morphologic and physiologic studies, the type
species of Apophysomyces is redefined as follows:
A. elegans Misra, Srivastava, and Lata (Figs. 2F,G; 3A–C).
Colonies attaining a diameter of 90 mm after 4 days at 37 1C on
CZA, whitish at first, becoming brownish grey, with scarce aerial
mycelium; reverse concolorous. Sporangiophores generally aris-
ing singly, emerging from aerial hyphae, straight or curved,
mainly unbranched or some times branched at the apex, light
greyish brown, with two types of morphology, i.e. (i) those that
were large (up to 540mm), bearing vase- or bell-shaped
apophyses (15–4611–40mm) and (ii) those that were shorter
(up to 400mm) and bore funnel-shaped apophyses (15–2015–
20mm), of 4–7.5mm wide, and smooth-walled. Sporangia pro-
duced terminally, pyriform, with distinct apophyses, and 20–
60mm in diameter. Sporangiospores ovoid, subspherical, broadly
ellipsoidal to barrel-shaped, frequently irregularly shaped, sub-
hyaline, smooth- and thin-walled, and 6–125–8mm. The strains
analyzed were able to assimilate esculin.
Similar colonies features as described on CZA were observed
on AS, PDA, and MEA, with the exception of lesser production
of mycelium in CZA. The optimum growth temperature was
35–42 1C and the minimum 15 1C. The fungus did not grow at 50 1C.Antifungal susceptibility tests
The results of antifungal susceptibility testing for Apophysomyces
strains are shown in Table 4. Amphotericin B and posaconazole were
the most active antifungal agents. Itraconazole and ravuconazole
were more active than voriconazole, and caspofungin and
anidulafungin were inactive against all strains.Discussion
Apophysomyces has been traditionally considered a monotypic
genus. However, on the basis of genetic, physiological, and
morphological data, we have demonstrated here that the genus
constitutes a complex of species. DNA sequences from three
different loci were analyzed to infer phylogenetic relationships
and species boundaries within strains morphologically identified
as A. elegans. The informations provided by the three loci
evaluated were similar, and proved to be useful markers for
species level differentiation in Apophysomyces. Although our study
included strains from very diverse origins, the number of isolates
we could obtain was small, and we anticipate even greater
diversity as more strains become available. Given this limitation
we were, however, able to recognize at least four phylogeneti-
cally, morphologically, and physiologically different species. The
shape and size of the sporangiospores, the type of the sporangio-
phore, and the shape of the apophyses were the most useful
characters for this purpose.
As carbon assimilation profiles can be useful for differentiation of
human pathogenic mucoralean genera,23 we tested the assimilation
of numerous carbon sources (Table 2). Low interspecific variability
within Apophysomyces was noted, with the only exception of esculin
assimilation, which was positive for A. elegans, and negative for the
ARTICLE IN PRESS
E. Alvarez et al / Rev Iberoam Micol. 2010;27(2):80–89 89
UNIVERSITAT ROVIRA I VIRGILI 
TAXONOMY AND PHYLOGENY OF CLINICALLY IMPORTANT MUCO ALEAN FUNG  
Eduardo Álvarez Duarte 
DL: T-1721-2011 other species in the complex. In this study, Apophysomyces strains also
showed negative results for D-galactose, amygdalyn, arbutin, salicin,
and gentiobiose assimilation, while in the study of Schwarz et al.23
these same tests were positive for the members of six other
pathogenic genera, i.e. Cunninghamella, Lichtheimia (Absidia), Mucor,
Rhizopus, Rhizomucor, and Syncephalastrum. In contrast, carbon
sources such as L-sorbose, L-rhamnose, dulcitol, inositol, erythritol,
D-arabinose, methyl-ß-D-xylopiranoside, methyl-D-mannopyrano-
side, methyl-D-glucopyranoside, D-tagatose, D-fucose, L-fucose, and
inulin were all negative for both the Apophysomyces strains and the
other six mentioned genera.23 Other carbon sources such as glycerol
were assimilated by Apophysomyces, Rhizopus, and Cunninghamella
but not by Lichtheimia, Rhizomucor, Mucor, and Syncephalastrum;
D-ribose was assimilated by Apophysomyces, Rhizopus, and Mucor and
not by Cunninghamella, Lichtheimia, Rhizomucor, and Syncephalastrum;
L-xylose was assimilated only by Mucor and some strains of Rhizopus,
and D-lactose was assimilated only by Lichtheimia, Rhizomucor, and
Syncephalastrum, although it was species dependent in Rhizomucor.
The nitrogen assimilation profiles and tolerance to various chemical
agents for the Apophysomyces strains tested in this study were non-
discriminatory (Table 3).
From a clinical point of view it is also worth mentioning that
none of the clinical strains included in this study belonged to
clade 2, which contains the type strain, A. elegans, and which has
previously been considered a pathogenic species. Clade 2 included
only two environmental strains isolated from Indian soils.
The in vitro activity of the antifungal drugs tested appeared to
corroborate data from previous studies.1,2,7,25Acknowledgments
This work was supported by the Spanish Ministerio de Ciencia y
Tecnologı́a Grants CGL 2007-65669/BOS and CGL 2009-08698/BOS.
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Saksenaea is a monotypic genus belonging to the order Mucorales and capable of producing severe
human infections. Through a polyphasic study based on analysis of the sequences of the internal tran-
scribed spacer (ITS) region, domains D1 and D2 of the 28S rRNA gene, and the elongation factor 1
(EF-1) gene, as well as by evaluation of relevant morphological and physiological characteristics of a set
of clinical and environmental strains, we have demonstrated that Saksenaea vasiformis is a complex of
species. We propose as new species Saksenaea oblongispora, characterized by oblong sporangiospores and
unable to grow at 42°C, and Saksenaea erythrospora, characterized by large sporangiophores and sporangia
and by ellipsoid sporangiospores, biconcave in the lateral view. Itraconazole, posaconazole, and terbin-
afine were active against all isolates included in the study, while amphotericin B, voriconazole, and the
echinocandins showed low activity.
The genus Saksenaea S. B. Saksena, belonging to the sub-
phylum Mucoromycotina, was first isolated from a forest soil in
India (38). Saksenaea vasiformis S. B. Saksena, the only species
of the genus, is a filamentous fungus reported in soil, drift-
wood, and grains (1, 12, 34), characterized by flask-shaped
sporangia, short sporangiophores, oval sporangiospores, and
dark rhizoids. It is a thermotolerant fungus that grows between
25°C and 44°C (13, 24, 44) and is able to cause severe human
infections in both immunocompromised and immunocompe-
tent hosts. Mucormycosis caused by S. vasiformis most often
occurs after traumatic implantation of the fungus but can also
be due to inhalation of spores (18), spider bites, insect stings,
and the use of indwelling catheters (11, 22, 28, 31). Clinical
cases seems to be more common in tropical and subtropical
climates than elsewhere and have been reported from Austra-
lia (16, 19, 22, 40, 48), India (6, 7, 11, 33), the United States (1,
8, 31, 35, 45), Thailand (44), Tunisia (28), the Middle East (2,
25), and Central and South America (9, 47).
Recent molecular studies, based mostly on internal tran-
scribed spacer (ITS) sequences, which have proven to be a
good phylogenetic marker in the Mucorales (5), have demon-
strated unexpectedly high genetic diversity within the most
relevant clinical species of this order (3, 4, 21). In the case of
Saksenaea vasiformis, a few studies have also demonstrated
relatively high intraspecific genetic diversity (9, 28), suggesting
that more than one phylogenetic species may be present within
this morphospecies.
To identify possible cryptic species in S. vasiformis, we per-
formed a polyphasic study, based on sequence analysis of three
loci, and evaluated different morphological and physiological
characteristics for a diverse panel of strains.
MATERIALS AND METHODS
Fungal strains. A total of 11 strains from different reference culture collec-
tions were included in the study (Table 1). They were provided by the American
Type Culture Collection (ATCC) Manassas, VA; the Centraalbureau voor
Schimmelcultures (CBS) Utrecht, Netherlands; the National Reference Center
for Mycoses and Antifungal Agents (NRCMA), Institut Pasteur, Paris, France;
the Facultad de Medicina de Reus (FMR), Reus, Spain; the Fungus Testing
Laboratory at the University of Texas Health Science Center (UTHSC), San
Antonio, TX; and the ARS (NRRL) Culture Collection, Peoria, IL. The strains
were cultured on potato dextrose agar (PDA; Pronadisa, Madrid, Spain) and
were incubated at 37°C  1°C for 2 to 5 days.
DNA extraction, amplification, and sequencing. For sequencing of the ITS
region, DNA was extracted and purified directly from fungal colonies by follow-
ing a slightly modified Fast DNA kit protocol (Bio 101, Vista, CA) consisting of
a homogenization step repeated three times with a FastPrep FP120 instrument
(Thermo Savant, Holbrook, NY). DNA was quantified with GeneQuant pro
(Amersham Pharmacia Biotech, Cambridge, England). The ITS was amplified
with the primer pair ITS5 and ITS4. The PCR mixture (25 l) included 10 mM
Tris-HCl (pH 8.3), 50 mM KCl, and 2.5 mM MgCl2 (10 Perkin-Elmer buffer II
plus MgCl2 solution [Roche Molecular Systems, Branchburg, NJ]), 100 M each
deoxynucleoside triphosphate (dNTP) (Promega, Madison, WI), 1 M each
primer, and 1.5 U of AmpliTaq DNA polymerase (Roche). The amplification
program for the three DNA fragments included an initial denaturation at 94°C
for 5 min, followed by 35 cycles of denaturation at 95°C for 30 s, annealing for
1 min at 56°C, and extension for 1 min at 72°C. A final extension step at 72°C for
7 min was included at the end of the amplification. The products were purified
with an Illustra GFX PCR DNA and gel band purification kit (General Electric
Healthcare, Buckinghamshire, United Kingdom) and were stored at 20°C until
they were used in sequencing. PCR products were sequenced by using the same
primers employed for amplification and following the Taq Dye Deoxy Termina-
tor cycle sequencing kit protocol (Applied Biosystems, Gouda, Netherlands).
Reactions were run on a 310 DNA sequencer (Applied Biosystems). Consensus
sequences were obtained using the Autoassembler program (Perkin-Elmer Ap-
plied Biosystems) and Seqman software (Lasergene, Madison, WI).
The D1 and D2 domains of the 28S rRNA gene (D1/D2) and the elongation
factor 1 (EF-1) locus were sequenced at the NRCMA. The mycelium was
grown as described previously (17). Genomic DNA was extracted for approxi-
mately 100 mg of mycelium. The mycelium was homogenized using green ce-
ramic MagNA lyser beads (diameter, 1.4 mm; Roche, Mannheim, Germany) for
* Corresponding author. Mailing address: Mycology Unit, Medical
School, Universitat Rovira i Virgili, C/Sant LLorenç 21, 43201 Reus-
Tarragona, Spain. Phone: 34 977 759350. Fax: 34 977 759322. E-mail:
josep.cano@urv.cat.
 Published ahead of print on 6 October 2010.
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three cycles of 30 s at 5,000 rpm. The tubes were then centrifuged, and 450 l of
supernatant was recovered. Three microliters of RNase A (100 mg/ml) was
added, and the tubes were incubated for 10 min at 65°C. DNA was then extracted
by using a DNeasy plant minikit (Qiagen, Germany) according to the manufac-
turer’s instructions.
D1/D2 was amplified with the primer pair NL-1 and NL-4 (26), and a small
region of EF-1 was amplified with primers MEF-11 and MEF-41 (32). PCR
amplification of D1/D2 and EF-1 and the corresponding sequence analysis were
carried out as described previously (17).
Phylogenetic analyses. The sequences were aligned using the Clustal X (ver-
sion 1.8) computer program, and alignments were corrected using the Gblocks
tool (version 0.91b) (10), followed by manual adjustments with a text editor.
Neighbor-joining (NJ) phylogenetic trees were constructed using the MEGA
package, version 4.1 (43). The distance matrix was based on the maximum
composite likelihood method with the pairwise deletion option.
For the phylogenetic inferences using maximum-likelihood (ML) analysis,
trees were inferred with PhyML (version 3.0) (20), and we used heuristic
searches, with starting trees obtained by random addition with 100 replicates and
nearest-neighbor interchange (NNI) branch swapping. For bootstrap ML anal-
ysis, we performed 1,000 replicates (NJ starting tree with NNI branch swapping).
Bayesian analyses were carried out using MrBayes, version 3.1 (23). Bayesian
analyses were performed by running 1,000,000 generations in four chains, saving
the current tree every 100 generations. The last 18,000 trees were used to
construct a 50% majority-rule consensus tree. The best-fit model of nucleotide
substitution for the combined data set selected by Modeltest (36) was the general
time-reversible (GTR) model (27, 37). Apophysomyces elegans (CBS 476.78) was
chosen as the outgroup.
Morphological study. The strains were subcultured on PDA, Czapek agar (CZA;
Difco, Becton Dickinson, France), and malt extract agar (MEA; 10 g of malt extract,
20 g of agar, and 1,000 ml of distilled water) and were incubated at 37°C. The
microscopic features were determined in wet mounts on water and on lactic acid,
which were examined under a light microscope. The strains were identified using the
traditional schemes based on morphological characteristics (13).
Physiological study. Growth rates at 4, 15, 24, 30, 35, 37, 42, and 50  1°C were
determined on PDA, MEA, and CZA for all strains. The petri dishes were
inoculated in the center and were incubated in darkness, and the colony diam-
eters (in millimeters) were measured daily.
Carbon source assimilation profiles were determined with the commercial API
50 CH kit (bioMérieux, Marcy-l’Etoile, France) by following protocols described
previously (39). The strains were cultured for 6 days on CZA at 37°C. A final
spore concentration of 5  105 CFU/ml was prepared in 20 ml of yeast nitrogen
base (7.7 g/liter; Difco, Becton Dickinson, France) containing 0.5 g/liter chlor-
amphenicol (Sigma-Aldrich Corp., St. Louis, MO) and 0.1% Bacto agar (Difco,
Becton Dickinson, France). Each well of the strips was inoculated with 300 l of
medium. The inoculated API 50 CH strips were incubated for 48 to 72 h at 37 
1°C in darkness. After incubation, the strips were read visually, and growth or
lack of growth was noted. Weak growth was considered a positive result. To
determine nitrogen source assimilation, we used the same inoculum described
above, except that the yeast nitrogen base broth was replaced with a carbon
nitrogen base broth (Difco, Becton Dickinson, France), and testing was per-
formed in sterile, disposable, multiwell microplates. The medium with the nitro-
gen sources was dispensed into the wells in 150-l volumes with a multichannel
pipette, and each well was inoculated with 50 l of the conidial suspension. The
microplates were incubated at 37°C in darkness for 48 to 72 h. We also evaluated
the growth of the strains on NaCl (at 2%, 5%, 7%, and 10%), 2% MgCl2, and
0.1% cycloheximide (14, 49). All tests were performed in duplicate. The produc-
tion of urease was determined after incubation on Christensen’s urea agar slants
at 37  1°C for 8 days (30).
Mating tests. The 11 Saksenaea strains were grown on CZA plates at 37  1°C
in the dark, after which they were paired in all combinations, including self-
crosses, on CZA. Each strain was streaked onto one-half of a CZA plate opposite
the streak of another strain, allowing for a central zone of contact when the
strains grew. Plates were incubated at 37  1°C and were examined macroscop-
ically each week for as long as 4 months for the presence of zygospores. All tests
were performed in duplicate.
Antifungal susceptibility testing. All strains were subcultured on CZA for 7 to
20 days at 30°C or 37°C. Sporangiospores were then collected in water, and the
suspension was adjusted to 2  104 CFU5/ml per well. Pure active powders, of
known potency, of amphotericin B (Sigma-Aldrich, Saint Quentin Fallavier,
France), voriconazole (Pfizer Central Research, Sandwich, United Kingdom),
itraconazole (Janssen-Cilag, Issy-les-Moulineaux, France), posaconazole (Scher-
ing-Plough Research Institute, Kenilworth, NJ), terbinafine (Novartis Pharma
AG, Basel, Switzerland), caspofungin (Merck & Co., Inc., Rahway, NJ), micaf-
ungin (Astellas Pharma, Osaka, Japan), and anidulafungin (Pfizer) were used.
Antifungal susceptibility testing was performed by a broth microdilution tech-
nique according to the guidelines of the Antifungal Susceptibility Testing Sub-
committee of the European Committee on Antibiotic Susceptibility Testing for
the testing of conidium-forming molds (41), with some modifications (17).
Nucleotide sequence accession numbers. All the sequences obtained in this
study have been deposited in the GenBank database and assigned the accession
numbers listed in Table 1.
MycoBank accession numbers. The descriptions and illustrations of Saksenaea
oblongispora and Saksenaea erythrospora are available online (http://www
.MycoBank.org/) under MycoBank accession numbers MB 518626 and MB
518627, respectively.
RESULTS
Phylogeny. With the primers used, we were able to amplify
and sequence 641 to 800 bp, 648 to 738 bp, and 486 to 532 bp
of the ITS, D1/D2, and EF-1 loci, respectively. The sequences
of the three loci were analyzed phylogenetically as separate
(data not shown) and combined data sets.
The topologies of the combined data sets by the three meth-
ods (NJ, ML, Bayesian inference) were very similar to those
observed in the particular trees of the different genes analyzed.
Most nodes in the combined analysis showed increased clade
TABLE 1. List of Saksenaea isolates included in the study
Isolatea Source
GenBank accession no.
ITS D1/D2 domains of28S rRNA gene EF-1
ATCC 28740 Craniofacial tissue and brain, Mississippi FR687322 HM776674 HM776685
ATCC 60625 Human wrist lesion at arterial catheter site, Louisiana FR687323 HM776675 HM776686
CBS 133.90 Forest soil, Brazil FR687324 HM776676 HM776687
CNRMAF/9-83 Skin lesion, France FR687325 HM776677 HM776688
FMR 10131 Cutaneous lesion, Tarragona, Spain FR687326 HM776678 HM776689
NRRL 2443T Soil, India FR687327 HM776679 HM776690
UTHSC 08-3606 Bovine fetus, Texas FR687328 HM776680 HM776691
UTHSC 09-528 Human tissue, United States FR687329 HM776681 HM776692
UTHSC 08-379 Eye, Utah FR687330 HM776682 HM776693
UTHSC 06-576 Blood, Middle East FR687331 HM776683 HM776694
UTHSC R-2974 Human tissue, Texas FR687332 HM776684 HM776695
a ATCC, American Type Culture Collection, Manassas, VA; CBS, Centraalbureau voor Schimmelcultures, Utrecht, Netherlands; CNRMA, Centre National de
Référence Mycologie et Antifongiques, Paris, France; FMR, Facultat de Medicina i Ciències de la Salut, Reus, Spain; NRRL, ARS Culture Collection (also known
as the NRRL Collection), Peoria, IL; UTHSC, Fungus Testing Laboratory, University of Texas Health Science Center, San Antonio, TX; T, type strain.
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support (70% bootstrap support for the NJ and ML meth-
ods; 0.95 for Bayesian inference). Analysis of the combined
partitions supports the recognition of three well-supported
clades (Fig. 1), each of which represents a different phyloge-
netic species. Clade 1 comprises eight strains from different
countries and sources, mainly from human and animal clinical
samples, including the type strain of S. vasiformis (NRRL
2443). This clade shows high intraspecific variability, with three
well-supported subclades, two of which contain only one strain
each (UTHSC 08-379 and ATCC 28740, respectively). The
third subclade contains six strains, including the type strain.
The genetic relationships of the members of the clade with the
type strain range between 84% and 94% identity, suggesting
that this clade represents a complex of species. Clade 2 in-
cludes two clinical strains from the United States, and clade 3
consists of only one strain from Brazil.
Of note, two additional clinical isolates, not shown in Fig. 1,
were included in the study. Phylogenetic analysis showed that they
belonged to clade 1 (CNRMAF/6-50, recovered from muscle
lesions of a French patient) and clade 2 (CNRMAF/4-81, from a
patient from French Guiana) (9) (data not shown). These isolates
were not viable, however, preventing any further study.
Physiology. The carbon assimilation patterns of all the
strains were positive in 12 tests (glycerol, D-adonitol, D-glucose,
D-fructose, D-mannose, D-mannitol, D-sorbitol, N-acetylglu-
cosamine, D-maltose, D-trehalose, amidon, and glycogen).
Thirty-two carbon sources were not assimilated by any strain
(erythritol, D-arabinose, L-arabinose, D-ribose, D-xylose, L-xy-
lose, methyl--D-xylopyranoside, D-galactose, L-sorbose, L-
rhamnose, dulcitol, inositol, methyl-D-mannopyranoside,
methyl-D-glucopyranoside, amygdalin, arbutin, esculin, salicin,
D-cellobiose, D-lactose, D-melibiose, D-saccharose, inulin, D-
melezitose, D-raffinose, gentiobiose, D-turanose, D-lyxose, D-
tagatose, D-fucose, L-fucose, and potassium 5-keto-gluconate).
The assimilation profiles of four carbon sources (xylitol, D-
arabitol, L-arabitol, and potassium gluconate) were strain de-
pendent. In contrast, variability in the assimilation of nitrogen
sources and the tolerance of NaCl, MgCl2, and cycloheximide
was null among the species. All the strains were positive for 10
nitrogen sources (creatine, creatinine, L-lysine, nitrate, L-tryp-
tophan, L-proline, L-leucine, L-ornithine, L-cysteine, and argi-
nine). Cadaverine and nitrite were not assimilated by any of
the strains. All strains were able to grow in 2% NaCl, 5% NaCl,
and 2% MgCl2 but failed to grow in 7% NaCl, 10% NaCl, and
0.1% cycloheximide.
None of the clades obtained in the phylogenetic analysis
showed distinctive physiological profiles.
Morphology. In general, all the strains examined displayed
the typical features of the genus Saksenaea. However, a more
detailed microscopic observation of these fungi showed impor-
tant and consistent differences among them, mainly in the
morphology of the sporangiophores and sporangiospores,
which correlated with the different clades observed in the phy-
logenetic analysis. The strains that made up clade 1, including
the type strain of S. vasiformis, showed the longest sporangio-
spores (5 to 7 by 2 to 3 m), which were mainly cylindrical, with
rounded ends. The sporangiospores of the strains in clade 2
were mostly ellipsoid, biconcave in a lateral view, and smaller
(5 to 5.5 by 2.5 to 3 m), while the sporangiospores of the clade
3 strain were mainly oblong, measuring 5 to 6.5 by 3 to 4.5 m
(Fig. 2). In addition, the strains of clade 2 showed clearly
longer sporangiophores and sporangia than the members of
the other clades (Fig. 3).
Mating test. After 4 months of incubation, no zygospore for-
mation was observed for any of the mating combinations per-
formed.
FIG. 1. Maximum-likelihood (ML) tree obtained from the combined DNA sequence data from three loci (ITS, D1/D2, EF-1). Numbers on
the branches are bootstrap neighbor-joining (NJ)/ML values above 75%, followed by Bayesian posterior probabilities above 0.95. Support values
of 75% (NJ/ML) and 0.95 (Bayesian posterior probabilities) are indicated by minus signs. T, type strain.
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FIG. 2. Morphology of the sporangiophores and sporangiospores of Saksenaea spp. (A, B, and C) S. vasiformis NRRL 2443. (A) Sporangio-
phore; (B) sporangiospores; (C) detail of the upper part of the sporangium. (D and E) Sporangiospores of S. erythrospora UTHSC 08-3606 (D) and
S. oblongispora CBS 133.90 (E). Bars, 10 m in panels A and B and 5 m in panels C, D, and E.
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Antifungal susceptibility testing. MICs were determined for
the nine strains that produced enough sporangiospores (all
except strains ATCC 60625 and ATCC 28740 from clade 1)
and are given below as geometric means (ranges), in micro-
grams per milliliter. High MICs of amphotericin B (4.1 [1 to 8])
and voriconazole (4.7 [2 to 8]) and high minimum effective
concentrations (MECs) of echinocandins (4.0 [4 to 8]) were
observed for all the strains tested. Itraconazole B (0.2 [0.06 to
1]), posaconazole (0.1 [0.06 to 0.25]), and terbinafine (0.1 [0.03
to 1]) had lower MICs. There was no apparent difference
between the species studied, but the small sample size prevents
statistical analysis.
TAXONOMY
Based on the morphological differences described, which
correlated with the molecular data, we conclude that clades 2
and 3 represent two species of Saksenaea different from S.
vasiformis, which we propose here as new species.
Saksenaea oblongispora Alvarez, Stchigel, Cano, Garcia-Her-
moso, et Guarro sp. nov. MycoBank MB 518626. See Fig. 2E
and 3C and D.
Coloniae in CZA rapide crescentes, albae, ex mycelium ae-
rium sparsum compositum. Sporangiophora erecta, plerumque
simplicia, 80 ad 100 m longa, 6 ad 10 m lata, supra massam
rhizoidalem saepe bifurcatam positis. Sporangia ampulli-
formes, 70 ad 110 m longa. Sporangiosporae plerumque ob-
longae, 5 ad 6.5 per 3 ad 4.5 m. Zygospora ignota.
Holotypus, CBS H-20471. Typus lectus in terra, Pará, Capi-
tâo Poço, Brazil, 1990 (cultura viva FMR 6500, CBS 133.90).
Etymology: the epithet refers to the oblong shape of the
sporangiospores.
Colonies filling the petri dish (diameter, 9 cm) after 4 days of
incubation at 37°C on CZA, whitish, with scarce aerial myce-
lium; hyphae branched, at first hyaline soon becoming light
brown, smooth-walled, 3 to 6 m in diameter; reverse concol-
orous. Sporangiophores erect, generally arising singly, hyaline,
unbranched, 80 to 100 m long, 6 to 10 m wide, with a
profusely dichotomously branched rhizoidal complex. Spo-
rangia terminal, multispored, hyaline, flask-shaped, asperulate
at low magnification, ornamented with many irregular, bacilli-
form protuberances under scanning electron microscopy
(SEM), 70 to 110 m long; with a long (60- to 90-m) neck;
apex of the neck closed with a mucilaginous plug, which is
gradually dissolved when mature. Sporangiospores mainly ob-
long, 5 to 6.5 by 3 to 4.5 m. Zygospores not observed.
Colonies on PDA and MEA showed features similar to
those on CZA, but they were more floccose and white, with
less sporulation. The optimum growth temperature was 25°C,
and the minimum temperature of growth was 15°C. The fungus
did not grow at 42°C.
FIG. 3. (A and B) Saksenaea erythrospora. (A) Sporangiophore; (B) sporangiospores, frontal and side views. (C and D) Saksenaea oblongispora.
(C) Sporangiophore; (D) sporangiospores, frontal and side views. (E and F) Saksenaea vasiformis. (E) Sporangiophore; (F) sporangiospores. Bars,
50 m for drawings A, C, and E; 5 m for drawings B, D, F.
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Saksenaea erythrospora Alvarez, Cano, Stchigel, Garcia-Her-
moso, et Guarro sp. nov. MycoBank MB 518627. See Fig. 2D
and 3A and B.
Coloniae in CZA rapide crescentes, albae, ex mycelium
aerium sparsum compositum. Sporangiophora erecta, plerumque
simplicia, 100 ad 150 m longa, 7 ad 11 m lata, supra mas-
sam rhizoidalem saepe bifurcatam positis. Sporan-gia ampul-
liformes, 100 ad 220 m longa. Sporangiosporae plerumque
ellipsoidae, maturitate membrana circa sporangiospore col-
lapsa, 5 ad 5.5 per 2.5 ad 3 m. Zygospora ignota.
Holotypus, CBS H-20472, ex fetu bovis, Texas, 2009 (cultura
viva FMR 10672, UTHSC 08-3606).
Etymology: the epithet refers the shape of the sporangio-
spores, resembling the biconcave form of erythrocytes.
Colonies filling the petri dish after 4 days of incubation at
37°C on CZA, whitish, with scarce aerial mycelium, branched,
hyaline, smooth-walled, 3 to 6 m in diameter; reverse con-
colorous. Sporangiophores erect, generally arising singly, at
first hyaline soon becoming light brown, generally straight,
unbranched, 100 to 150 m long, 7 to 11 m wide. Sporangia
terminal, multispored, flask-shaped, asperulate, ornamented
with many irregular, small bacilliform protuberances under
SEM, 100 to 220 m long; with a long (80- to 200-m) neck;
apex of the neck closed with a mucilaginous plug. Sporangio-
spores mostly ellipsoid, biconcave in a lateral view, smooth-
walled, their membranes collapsing at maturity, 5 to 5.5 by 2.5
to 3 m. Zygospores not observed.
Colonies on PDA and MEA showed features similar to
those on CZA, but they were more floccose and white, with
less sporulation. The optimum growth temperature was 25°C,
and the minimum was 15°C. The fungus grew at 42°C and did
not grow at 50°C.
Based on our morphological and physiological studies, the
type species of Saksenaea is redefined as follows.
Saksenaea vasiformis S. B. Saksena (Saksena, 1953). See Fig.
2A to C and 3E and F.
Colonies filling the petri dish after 4 days at 37°C on CZA,
whitish, with scarce aerial mycelium; reverse concolorous. Spo-
rangiophores generally arising singly, emerging from aerial
hyphae, straight, mainly unbranched, at first hyaline soon be-
coming light brown, 65 to 100 m long, 6 to 10 m wide.
Sporangia produced terminally, flask-shaped and at low mag-
nification asperulate, ornamented with small and irregular ba-
cilliform protuberances under SEM, up to 110 m long; with a
long (60 to 90 m) neck; apex of the neck closed with a
mucilaginous plug, which gradually becomes dissolved when
mature. Sporangiospores mainly cylindrical, with rounded
ends, hyaline, 5 to 7  2 to 3 m.
Colonial features similar to those described on CZA were
observed on PDA and MEA, except for reduced mycelium
production in the former. The optimum growth temperature
was 25°C to 37°C, and the minimum was 15°C. The fungus grew
at 42°C and did not grow at 50°C.
DISCUSSION
Despite its reproducibility in severe human infections, Sak-
senaea remains a poorly studied mucoralean genus, mainly due
to the lack of sporulation on the mycological culture media
routinely used in clinical laboratories and the scarce number of
strains preserved in culture collections. Here we demonstrated
high genetic and phenotypic diversity among the 11 strains
studied based on a polyphasic approach. The information pro-
vided by the three loci evaluated was similar, and they proved
to be useful markers for species-level delimitation in Sak-
senaea. The genus was determined to be genetically heteroge-
neous, comprising several species. Apart from the type species,
at least other two species were characterized phenotypically.
The shape and size of the sporangiospores, the length of the
sporangiophore and sporangia, and the maximum temperature
of growth were the most useful characteristics for their recog-
nition.
Carbon assimilation profiles can be useful for the differen-
tiation of human pathogenic mucoralean fungi at the genus
level. In the case of Saksenaea, the test for assimilation of
D-cellobiose was negative, while this test was positive for the
other genera tested in previous studies (4, 39). However, none
of the physiological tests evaluated in this study were discrim-
inatory at the species level.
Antifungal susceptibility profiles also were not discrimina-
tory. However, they matched previously published results (42)
for the order Mucorales, except for amphotericin B, which has
higher MICs for Saksenaea than Mucor spp.
Up to now, approximately 40 cases of zygomycete infec-
tions, mostly cutaneous infections, have been attributed to
Saksenaea (6, 40, 46, 47), although for the reasons indicated
above, it is likely that the actual number of clinical cases has
been underestimated. To avoid difficulties in the detection
and identification of Saksenaea in clinical samples, several
authors have emphasized the need for special culture tech-
niques, such as the use of floating agar blocks on water, or
the use of Borellis lactrimel agar (15, 29) to induce sporu-
lation. However, our use of these techniques yielded poor
results (data not shown). In contrast, the use of Czapek
agar, a culture medium traditionally used for the phenotypic
characterization of Aspergillus and Penicillium species, pro-
duced good in vitro sporulation of the Saksenaea strains
tested in this study. This medium also worked well for the
sporulation of another mucoralean genus, Apophysomyces,
which also sporulates poorly in routinely used mycological
media, such as Sabouraud agar or PDA (4).
In addition to the two new species described here, the
phylogenetic analysis also demonstrated the existence of
more cryptic species within the first clade. However, since
these strains could not be distinguished by using phenotypic
characteristics, we prefer to refer to clade 1 as Saksenaea
vasiformis complex. Although our study included strains of
diverse origins, the number we could obtain was small, due
to the fact that most of the clinical isolates previously re-
covered were not kept in culture collections and/or were no
longer viable. It is likely that when more strains become
available, additional new species within the genus Saksenaea
will be identified.
The study performed here and the DNA sequences gen-
erated should be useful for further characterization of clin-
ical isolates and/or identification of causative species from
tissue biopsy specimens. They may also allow the identifica-
tion of other species within the genus or the S. vasiformis
complex.
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The Mucorales have been known as etiological agents of human infections for 
more than 100 years (Dannaoui and Garcia-Hermoso, 2007; Platauf, 1885; Ribes, 
2000). However, the biology of these fungi and the epidemiology of the diseases that 
they cause are still poorly known. This is due to the relatively low frequency of these 
infections, despite the continuous increase in the number of immunocompromised 
people (diabetics, immunodeficiency, transplants, haematological malignancies, AIDS), 
who are especially susceptible hosts; but it is also due to the difficulty of their isolation 
and identification at generic and species level, because of their (presumed) poor 
morphological differentiation. Moreover, two emergent mucoralean pathogens that 
affect people who are not immunocompromised, Apophysomyces elegans and 
Saksenaea vasiformis, fail to produce fertile structures on the culture media that is 
usually employed in the clinical microbiology lab. 
 Roden et al. (2005) reviewed an impressive number of clinical cases of 
mucormycosis (ca. 1000), with a detailed relation of the species involved in such 
infections. That study revealed that the etiological agent was identified at species level 
in only 50% of cases, and even in those cases identification was doubtful since the 
mycological methods were not indicated and in numerous cases were carried out by non 
expert laboratories. Consequently, the value of those data is relative and must be taken 
with caution. Regarding that, we carried out a preliminary study (Alvarez et al., 2009), 
in order to investigate the spectrum of species involved in mucormycosis in the United 
States of America, a large number of isolates having been made available by University 
of Texas Health Science Center at San Antonio (UTHSC), an institution with whom we 
have frequently collaborated in different investigations. In that work we studied 190 
mucoralean isolates, which is the largest set of clinical isolates ever examined in a 
single study up to now. One of the most relevant findings of our study was to 
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demonstrate that practically all the species involved in mucormycosis (a total of 9) 
could be reliably identified using accurate phenotypic methods. When we compared the 
identification using morphological and physiological criteria against that using the 
Basic Local Alignment Search Tool (BLAST) search employing ITS nucleotide 
sequences, we found 100% concordance of the identifications at generic level, and 92% 
at species level. Only 7.2% of the isolates were not identified using the 
sequencing/Blast search. Among them, seven of the isolates of Mucor spp. presented 
little similarity with the sequences of the species of this genus deposited in GenBank. 
For three of these isolates, phenotypically identified as M. ramosissimus the BLAST 
search showed a low similarity (94-95%) with the type strain of the species. The three 
remaining isolates, which were initially morphologically identified as M. racemosus, 
also showed a low similarity (90-91%) with the sequence of the type strain of this 
species when the BLAST search was made. A seventh isolate, belonging to the genus 
Mucor, was not possible to identify using both phenotypic and molecular tools although 
it showed certain morphological features related to M. indicus. As a result, the 
phylogram inferred using the 5.8S rRNA nucleotidic sequences from our isolates and 
reference/ex-type strains, all those isolates of Mucor were placed in separated clusters, 
in reference to the most morphological and molecularly related species. On the other 
hand, the placement of Rhizomucor pusillus (the type species of the genus) distant from 
the Mucor clade, and the inclusion of Rhizomucor variabilis var. regularior in the 
Mucor circinelloides clade meant that the former must be considered a synonym of M. 
circinelloides. Something similar happened with Rhizomucor variabilis var. variabilis, 
which clustered with M. hiemalis, but the morphological differences and the genetic 
distance supports leaving them as two separated species. Rhizopus oryzae, as in other 
studies (Ribes et al., 2000; Roden et al., 2005), was the most frequently isolated in the 
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studied cases (44.7%), followed by R. microsporus (22.1%), Mucor circinelloides 
(9.5%), Lichtheimia corymbifera (5.3%), Rhizomucor pusillus (3.7%), Cunninghamella 
bertholletiae (3.2%), Mucor indicus (2.6%), Cunninghamella echinulata (1%), and 
Apophysomyces elegans (0.5%). In reference of the origin of the isolates, the majority of 
them were from cutaneous infections (28%), lungs (26.8%), and sinuses (25.8%). The 
remaining isolates comprised a subset collected from different deep sites. These results 
differ from those obtained by Roden et al. (2005), who found that the most commonly 
involved anatomical sites were the sinuses (39%), followed by lungs (24%) and 
cutaneous presentations (19%), among others.  
Despite the proposal of Balajee et al. (2009) to establish a 99% of identity in the 
nucleotide sequence of ITS region as the cut-off to consider two isolates as pertaining to 
the same mucoralean species, the higher intraspecific variability that we found in our 
isolates, and because the unreliability of some sequences available in the nucleotide 
databases (ie., GenBank), we proposed decrease the cut-off to 98% of identity. In this 
sense, it still needs to be clarified whether Cunninghamella bertholletiae, which 
presented a high genetic variability in the 5.8S rRNA gene sequences, contain several 
cryptic species or if the cut-off should be reviewed again. 
 Apophysomyces was a monotypic genus erected by Misra (Misra et al., 1979) to 
accommodate a single species, A. elegans. However, the results obtained in our first 
study (Alvarez et al., 2009), showed a high intraspecific variability in the ITS 
nucleotide sequences between our isolates and with respect to those of the type strain. In 
addition, some previously reported findings suggested that more than one phylogenetic 
species might be present within the morphospecies A. elegans (Chakrabarti et al., 2003). 
Based on these previous observations, and due to the availability of 16 strains from 
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different geographic areas and origins (mostly clinical, but also environmental), we 
performed a polyphasic study consisting of a phenotypic (morphological and 
physiological) and a genotypic characterization. We carried out a multilocus study 
based on the analysis of the nucleotide sequences of the ITS region, D1-D2 domains, 
and a fragment of the H3 gene. Our results suggested the existence of three new 
phylogenetic species plus A. elegans, which could be confirmed morphologically.  
Because the origin of the isolates included in the type species clades, including the type 
strain, is exclusively environmental (soil samples), we concluded that A. elegans, 
traditionally considered an etiological agent of mucormycosis, has not been involved in 
clinical so far. However, the three new species, A. ossiformis (morphologically 
characterized by its bone-shaped spores), A. trapeziformis (producing trapezoid-shaped 
spores) and A. variabilis (which form sporangiospores variable in shape and size), 
would be the real etiological agents of mucormycosis, particularly the latter, because 
they are mostly from clinical (human and animal) origin. Recent studies confirmed the 
clinical importance of A. variabilis isolates (Guarro et al., 2011; Chakrabarti et al., 
2010). 
 In addition to these taxonomical and epidemiological findings, we demonstrated 
the usefulness of Czapek agar to stimulates the production of fertile structures 
(sporangiophores and sporangiospores), which are critical in routine (morphological) 
identification. Other tools, such as the use carbon assimilation profiles, has proven 
useful for the identification of human pathogenic mucoralean fungi (Schwarz et al., 
2007), but for the case of the four species of Apophysomyces a low interspecific 
variability was noted, with the exception of the hydrolysis and assimilation of the 
esculin, which were positive only for both isolates of A. elegans. 
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 Mucor is a genus that has been the subject of several taxonomical changes in 
the past years, being divided into several sections based on growth temperatures, length 
of the sporangiophores, size of the sporangium, size and shape of sporangiospores, etc. 
(Schipper 1973, 1975, 1976, 1978; Zycha et al., 1969). In our first study (Alvarez et al., 
2009) seven of the 30 isolates belonging to the genus Mucor were not identified at 
species level because of the differences in their nucleotide sequences (ITS region) with 
respect to the morphological closest related species. Previously, only five species had 
been reported in clinical infections: Mucor indicus, M. circinelloides, M, racemosus, M. 
ramosissimus, and M. hiemalis (Prabhu and Patel, 2004; de Hoog et al., 2000). In order 
to determine the possible existence of cryptic species in this set of unclassified isolates, 
we performed a polyphasic study (Alvarez et al., 2011), which included the phenotypic 
analysis of the morphologically closest related species, and a phylogenetic study using 
the nucleotide sequences the ITS region and the D1 and D2 domains of the 28S rDNA. 
This polyphasic study revealed the existence of two new species: Mucor ellipsoideus 
and Mucor velutinosus. The first one, constituted only by a single isolate, clustered 
together M amphibiorum and M. indicus. However, M. ellipsoideus produces narrowly 
ellipsoidal (and flattened in one side) spores, whereas they are smaller and globose and 
regularly ellipsoidal in M. amphibiorum and in M. indicus, respectively. Mucor 
velutinosus included three of the previously unidentified isolates, and formed a well 
supported cluster closely related to M. circinelloides (f. circinelloides and f. lusitanicus) 
and M. ramosissimus. However, M. velutinosus could be clearly differentiated from 
these species because of the production of larger and ornamented spores in the former. 
The most morphologically related species to M. velutinosus, i.e. M. amphibiorum, M. 
fuscus and M. plumbeus, were placed phylogenetically distant, and could easily be 
differentiated from the former because they failed to growth at 37ºC. Recently, this new 
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species has been involved in a disseminated skin infection in a female patient with acute 
myeloid leukemia (Sugui et al., 2011). The remaining three previously unidentified 
isolates were placed in both phylograms together with reference strains of Mucor 
circinelloides f. lusitanicus. Due to the genetic and morphological differences between 
the reference strains and our clinical isolates of M. circinelloides f. lusitanicus with the 
reference strains of M. circinelloides f. circinelloides, we proposed that both formae 
belonged to different species: Mucor circinelloides and M. lusitanicus. On the other 
hand, the M. fragilis strains included in this study were placed in the same clade as the 
other M. lusitanicus strains, based on the fact that we did not find any morphological or 
physiological differences with the M. lusitanicus strains. Furthermore in the absence of 
a type strain of the former, they could be considered as pertaining to M. lusitanicus. 
Another interesting finding was the confirmation of Rhizomucor variabilis var. 
variabilis as a species belonging to the genus Mucor. Rhizomucor variabilis var. 
variabilis was genetically closely related to Mucor hiemalis and Mucor mucedo and 
very distant from Rhizomucor pusillus, the type species of the genus. For this reason, 
and despite their ability to produce rhizoids, we suggested the reclassification of 
Rhizomucor variabilis var. variabilis as Mucor irregularis. Our proposal has recently 
been supported by Schell et al. (2011), who also reported new cases of mucormycosis 
due to M. irregularis from the U.S.A. Our study therefore confirmed the polyphyly of 
the genus Mucor, shown by other authors (O`Donnell et al., 2001; Schell et al., 2011), 
sharing common ancestors with species not related morphologically to other genera like 
Chaetocladium, Backusella, Ellisomyces and Kirkomyces.  
 Saksenaea is a genus considered an emerging pathogen, mainly in India 
(Baradkar and Kumar, 2009). Several authors have reported an unexpected high genetic 
diversity among sequences from isolates morphologically identified as Saksenaea 
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vasiformis, suggesting that more than one phylogenetic species may be present within 
this morphospecies (Blanchet et al., 2008; Lechevalier et al., 2008). Based on these 
results, we carried out a polyphasic study, analyzing three molecular markers (the ITS 
region, the D1-D2 domains, and a fragment of the EF-1α gene) to establish the 
phylogenetic relationships for a diverse panel of 11 clinical and environmental isolates 
of Saksenaea vasiformis, including the type strain. In the tree of the combined dataset, 
we observed three well supported clades. Within the main clade, which includes the 
type strain of the genus, we can found some well supported sister clades, that could be 
considered as potential phylogenetic cryptic species, especially if we consider the high 
genetic variability between the isolates (with less than 94 % of the nucleotide sequence 
identity among them). However, these isolates could not be distinguished 
phenotypically (they all produced short sporangiophores and more or less cylindrical 
spores; and grew at 42ºC), so we preferred to refer to this clade as Saksenaea vasiformis 
complex. A future study, that includes more isolates and analyses a bigger panel of 
physiological characters (i.e. the identification of extrolytes and structural 
polysaccharides) and many more molecular markers, perhaps could to separate these 
cryptic species. The other isolates formed another two well supported clades, also 
showing morphological and physiological features that allowed us to describe them as 
two new species: Saksenaea erythrospora (forming long sporangiophores, and ellipsoid 
sporangiospores, but biconcave in lateral view; and growing at 42ºC) and S. 
oblongispora (with short sporangiophores, and oblong-shaped sporangiospores; and not 
growing at 42ºC). As for the Apophysomyces species, the physiological tests were not 
useful for discriminating between the Saksenaea species. 
Up to now, the prognosis in mucormycosis infections remains poor, with high 
mortality rates of approximately 50% (Roden et al., 2005; Skiada et al., 2011). This 
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could be explained by the high variability in the susceptibility patters to antifungal 
drugs (Almyroudis et al., 2007; Dannaoui et al., 2002a, 2002b, 2002c, 2003a, 2003b; 
Sun et al., 2002a). Based on our results (Alvarez et al., 2010a, 2010b), amphotericin B 
is the most active antifungal drug in vitro against the species studied. This is the case of 
our new species of Mucor, M. ellipsoideus and M. velutinosus, which showed that 
amphotericin B was active against all isolates, and posaconazole and itraconazole 
showed a low activity (Alvarez et al., 2011). In the case of A. elegans and the new 
species A. ossiformis, A. trapeziformis and A. variabilis (Alvarez et al., 2010b), 
amphotericin B again and posaconazole were the most active antifungal agents, whereas 
itraconazole and ravuconazole were more active than voriconazole, and caspofungin 
and anidulafungin were inactive against all strains. However, the isolates of Saksenaea 
that we studied showed a significant difference with respect to the other Mucorales 
assayed. We found that itraconazole, posaconazole and terbinafine were active against 
all Saksenaea isolates (Alvarez et al., 2010a), while amphotericin B, voriconazole, and 
the echinocandins showed low activity. These results are in concordance with previous 
reports (Almyroudis et al., 2007; Sun et al., 2002a). Based on our results, and in 
agreement with other authors (Dannaoui et al., 2003b; Sabatelli et al., 2006; Sun et al., 
2002a) we propose the use of pozaconazole as the second line of antifungal drugs (the 
first line in cases of Saksenaea spp. infections), because it has a lower toxicity than 
other antifungals (Stewardson et al., 2009). 
 Overall, given the high variability of the susceptibility patterns in the Mucorales, 
we have demonstrated that a correct identification of the etiological agent, through the 
use of classical and molecular tools will lead to a correct therapy. 
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1. Phenotypical and molecular methods were used to identify 190 isolates of species of 
the order Mucorales that had been isolated from clinical samples, mainly in United 
States of America. The correlation between the two methods was 92%.  
 
2. Rhizopus oryzae was the most common species isolated from clinical samples 
(44.7%), followed by Rhizopus microsporus (22.1%) and Mucor circinelloides (9.5%). 
 
3. We demonstrated that by the use of the internal transcribed spacer region it was 
possible to discriminate between closely related species in all genera studied. 
 
4. Three new species of Apophysomyces: Apophysomyces ossiformis, A. trapeziformis 
and A. variabilis have been proposed, based on a polyphasic study that included the 
sequencing of the histone 3 gene, the internal transcribed spacer region and domains D1 
and D2 of the 28S rRNA gene, as well a detailed morphological and physiological 
study.  
 
5. Our results suggest that Apophysomyces elegans, was not the etiological agent of 
mucormycosis in humans, as previously reported being mainly isolated from soil. The 
other 3 new species, especially A. variabilis, were related to clinical cases. 
 
6. Two new species of Mucor, Mucor ellipsoideus and M. velutinosus were proposed, 
based on morphology, physiology and DNA sequence data. 
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7. We demonstrated that Rhizomucor variabilis var. variabilis and Rhizomucor 
variabilis var. regularior, were morphologically and genetically related to Mucor, being 
relocated in this genus. 
 
8. Two new species of Saksenaea: Saksenaea erythrospora and S. oblongispora were 
proposed, based on morphology, physiology and a multilocus study. 
 
9. A multilocus analysis revealed that Saksenaea vasiformis was a complex species with 
poor morphological differentiation. 
 
10. We corroborated that amphotericin B remains the most active antifungal drug 
against the majority of the isolates of Mucorales tested in this study. Posaconazole and 
itraconazole showed high antifungal activity, particularly against Saksenaea species. 
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